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ABSTRACT
Children diagnosed with sickle cell disease (SCD) struggle with executive functions (EF);
however, there is a paucity of research on neuropsychological outcomes in adults with SCD. This
study aimed to examine differences in EF between adults with SCD and healthy controls. Thirtyone patients with SCD and 34 healthy controls (ages 18-45) participating in an IRB-approved
Children’s Hospital Los Angeles (CHLA) study of cerebral blood flow underwent
neuropsychological evaluation using the Delis–Kaplan Executive Function System (D-KEFS)
Trail Making and Color Word Interference Tests and the Wechsler Adult Intelligence Scale Fourth Edition (WAIS-IV) Digit Span subtest to assess various aspects of EF. The Wechsler
Abbreviated Scale of Intelligence - Second Edition (WASI-II) was administered to estimate
general intellectual ability. There were no significant differences between groups related to age,
gender, race, parental education, or general intellectual ability; however, the control group was
estimated to have significantly higher current combined annual family income as compared to
patients with SCD, x2 (6, N = 65) = 10.87, p = .02. Therefore, income was statistically controlled
for during analyses. Both groups performed in the solidly average range across EF measures and
no significant differences were noted between groups in working memory, F(1) = .009, p = .93,
ηp2 = .000; inhibition, F(1) = .156, p = .03, ηp2 = .03; or cognitive flexibility, F(1) = 3.11, p =
.08, ηp2 = .06. Adults with SCD in this study performed comparably to healthy controls. Early
treatment with hydroxyurea to the maximum tolerated dose may improve prognosis and serve as
a protective factor against EF deficits in adults with SCD. However, additional research is
needed to better understand how treatment protocols influence neuropsychological outcomes in
this population.
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Chapter 1: Statement of the Problem
Sickle cell disease (SCD) refers to a group of inherited disorders characterized by two
sickle cell genes (one gene is required from each parent) in which misshapen blood cells lead to
anemia among other complications (National Heart, Lung, and Blood Institute [NHLBI], n.d.).
These disorders result in a range of complications including episodes of intense pain, stroke,
susceptibility to infection, academic challenges, and changes in cognitive functioning (Centers
for Disease Control and Prevention [CDC], 2016; Manci et al., 2003).
SCD most commonly affects individuals of African ancestry (e.g., African American,
Afro-Caribbean); however, there is also occurrence in individuals of Mediterranean, Middle
Eastern, Asian Indian, and South or Central American descent (Brousseau, Panepinto, Nimmer,
& Hoffmann, 2010; Hassell, 2010; Nelson & Hackman, 2013; Quinn, Rogers, McCavit, &
Buchanan, 2010; Rees, Williams, & Gladwin, 2010; Yanni, Grosse, Yang, & Olney, 2009). In
the United States (U.S.), approximately 1 in 365 African American children (approximately 8%)
are diagnosed with SCD as compared to the next most common community, which is 1 in 16,305
Latinos (approximately 0.00006%; Hassell, 2010; Huttle, Maestre, Lantigua, & Green, 2015;
NHLBI, n.d.). The descendants of those most commonly affected hail from regions with a
relatively recent history of pervasive malaria infection (Aidoo et al., 2002; Allison, 1954; Gilles
et al., 1967). The single sickle cell gene has served an adaptive function in these populations, as
it protects those with sickle cell trait (SCT; i.e., one sickle gene as opposed to two) against death
from malaria. The malaria parasite lives in the red blood cells of its host; however, due to
premature hemolysis (i.e., breakdown) of sickled red blood cells, the parasite is unable to
reproduce (Wiesenfeld, 1967). This clearly provides a distinct advantage for those individuals
who face potential death due to malaria exposure, although in areas where the disease is rare,
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sickled red blood cells provide no benefits to survival for the population as a whole. Unlike their
SCT counterparts, those with SCD are generally more susceptible to infection (Platt et al., 1994).
Due to the slave trade’s strong tie to our nation’s history, there exists a significant
population of African Americans in the United States (U.S.). Unfortunately, their health and
prosperity have not been an area of great focus since the abolition of slavery (Phillips, 1999) and
African Americans have faced alarming health disparities in this nation (CDC, 2005; Landrine &
Corral, 2009; Orsi, Margellos-Anast, & Whitman, 2010). During the 1960s and ‘70s, the sickle
cell cause became a focus within the civil rights movement with activists citing the reality that
most patients with SCD did not live beyond their teenage years (Scott & Castro, 1979; Wailoo,
2014). In response to calls for action, the Sickle Cell Anemia Control Act was passed into law in
1972 which allocated federal funding for the research, education, screening, and treatment of
SCD.
At the time of the Sickle Cell Anemia Control Act, the majority of SCD-related deaths
occurred in early childhood, leading the disease to be considered a pediatric condition (Gill et al.,
1995; Lee, Thomas, Cupidore, Serjeant, & Serjeant, 1995). However, in the 1990s, the average
life expectancy for individuals with SCD jumped to the 40s (Platt et al., 1994). This is
attributable to newborn infant screening programs (i.e., state-mandated targeted genetic testing
for all newborns) which began to include SCD in the 1960s and ‘70s, the use of prophylactic
antibiotics and vaccinations, as well as the rise of treatments such as blood transfusion and
hydroxyurea (Chaturvedi & DeBaun, 2016; El-Haj & Hoppe, 2018; Gaston et al., 1986; Lopes de
Castro Lobo et al., 2013; Yanni et al., 2009). As patients with SCD are beginning to live much
longer than they have in the past, it is increasingly important to understand the disease in adult
populations. Lanzkron, Carroll, and Haywood (2013) found that the adult mortality rate
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increased by 1% annually between 1979 to 2005, while the pediatric mortality rate decreased by
3% annually during the same time period (both p < 0.001). While these patterns in mortality may
be reflective of an increase in life expectancy in SCD patients, the investigators note that it is
likely that this at least partially reflects a lack of access to comprehensive adult care. Further,
young adults transitioning from pediatric to adult care are at the highest risk for death (Quinn et
al., 2010), many of which are related to acute medical events which suggests that these
individuals may have not been able to sufficiently establish connections with adult specialists.
This has occurred alongside a relative increase in research and comprehensive care in pediatric
SCD when compared to adults (Grosse et al., 2011). This disparity in adult SCD care may be
ameliorated following an increase in research focused on the needs of patients as they transition
from pediatric to adult care.
In addition to medical research, increased life expectancy necessitates a better
understanding of the neuropsychological impact of SCD in adults. A growing body of literature
has contributed to our understanding of the neuropsychological effects of SCD in the pediatric
population, particularly related to executive functions (EF) which are higher order cognitive
skills necessary for mental planning, organization, and execution/completion of purposeful, goaloriented tasks. However, a relative paucity exists when considering the effects in adults. This
study aims to inform a greater understanding of the effect of SCD on EFs in the adult population.
More specifically, the study will determine whether previous research demonstrating decreased
performance among children with SCD will be replicated within an adult SCD sample.
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Chapter 2: Review of the Literature
Sickle Cell Disease (SCD) refers to a group of inherited red blood cell disorders whose
primary physical feature is abnormally shaped hemoglobin - a protein that carries oxygen
through the body via red blood cells (Howard & Telfer, 2015; Ilesanmi, 2010; Kral, Brown, &
Hynd, 2001; NHLBI, n.d.). Typical hemoglobin in adults is known as hemoglobin A (HbA). The
disc shape of HbA allows the cells to easily move through blood vessels without sticking to
vessel walls or becoming obstructed. Sickle hemoglobin, known as hemoglobin S (HbS), is
shaped like a crescent, or sickle, as the name implies. This results in cells that stick to vessel
walls, particularly fine capillaries and arterioles, causing partial or complete obstruction, and
impaired delivery of oxygen throughout the body. Over time, sickled blood cells cause
irreversible damage to blood vessel membranes as they attempt to squeeze through the small
passageways, which leads to dehydration of the cells.
Genotypes
As SCD refers to a group of disorders, there are various genotypes through which the
disease can be manifested (Kral et al., 2001). The most common and severe genotype of SCD is
hemoglobin SS (HbSS) which is also known as sickle cell anemia1 (SCA). Other forms of SCD
also have their names derived from the type of hemoglobin inherited (e.g., HbSC, HbSD, HbSE;
CDC, 2016). The complications typical of each genotype vary in quality and severity. As of
2006, all states within the U.S., including Puerto Rico and the U.S. Virgin Islands, mandate
HbSS testing as part of the standard newborn screening tests (Benson & Therrell, 2010). This
early screening allows prompt diagnosis and subsequent medical care at

Some practitioners also include the genotype Sβ0-thalassemia (HbSβ0-thalassemia) in SCA as
the subtypes present similarly (NHLBI, 2014).
1
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specialized treatment centers where available (Raphael, Kavanagh, Wang, Mueller, &
Zuckerman, 2011). Screening is particularly important as infants with SCD typically do not
initially show signs of the disease due to the protective nature of fetal hemoglobin (HbF), which
is in dominant production until approximately 6 months of age (Edoh, Antwi-Bosaiko, &
Amuzu, 2006; Watson, Stahman, & Bilello, 1948). While adults retain the capacity to produce
HbF, levels of production drop to less than 1% by age 2, which is below clinical significance
(Mosca, Paleari, Ivaldi, Galanello, & Giordano, 2009, Thein & Menzel, 2009). There is evidence
to suggest that in some cases, elevated levels of HbF continue to be produced into adulthood,
which assists in managing pain crises (Edoh et al., 2006; Gardner & Thein, 2016); however, this
only occurs in approximately 10% of the general population (Thein & Craig, 1998; Thein &
Menzel, 2009).
In addition to the aforementioned SCD genotypes, there are also individuals with Sickle
Cell Trait (SCT). In order to acquire SCD, a child must receive two genes for SCD – one from
each parent (CDC, 2016). However, individuals with SCT received only one of these genes, and
as a result, they are carriers for the disorder although they do not experience the full range of
symptoms. Despite this, there are rare, yet serious complications that may occur even with SCT.
These include blockages in small blood vessels in very low oxygen conditions (e.g., high
altitude, physical exertion), increased susceptibility to infection, kidney cancer, and reduced
blood flow to the spleen (American Society of Hematology, n.d.; Eichner, 2007; Thogmartin et
al., 2011; Yanamandra, Das, Malhotra, & Varma, 2018). As SCD is an autosomal recessive
condition, individuals with SCT may also pass SCD along to their children if that child receives
one sickle cell gene from each parent.
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Medical Complications
The primary function of hemoglobin is to transport oxygen to organs throughout the body
(Kral et al., 2001). One of the most common complications of SCD is poorly oxygenated tissue
(i.e., hypoxia) due to the misshapen, inefficient hemoglobin S, which results in vaso-occlusive
crises (also known as VOCs, pain crises, and acute painful episodes; NHLBI, n.d.; Serjeant &
Serjeant, 1992). This mild to extremely severe pain is caused when blood flow is disrupted in
small blood vessels (CDC, 2016). The pain may be described as throbbing, sharp, or gnawing
(Rees et al., 2003). These episodes are the most frequent reason for emergency room visits for
patients with SCD (CDC, 2016). Additionally, sickled blood cells last only 10 to 20 days as
compared to 90 to 120 days for normal cells, requiring increased speed in replenishment. The
body has difficulty keeping up with the production of new red blood cells, leading to anemia,
which may be manifested as lethargy, slowed growth, or delayed puberty. Other common
complications of SCD include hand-foot syndrome (i.e., swelling in the hands and feet as a result
of sickled blood cells obstructing blood flow in the extremities), increased risk for infection,
acute chest syndrome (i.e., life-threatening chest pain, coughing, difficulty breathing, and fever),
splenic sequestration (i.e., life-threatening enlargement of the spleen), ischemic priapism (i.e.,
painful, prolonged erections), vision loss, and increased risk for blood clots. Over time,
significant damage can occur to body organs, tissues, and/or bones due to insufficient blood
flow. Infection, heart disease, stroke, and liver disease are leading causes of death in the SCD
population (Lanzkron et al., 2013). Despite increased understanding of the disease processes
involved with SCD as well as revised treatment recommendations, recent research suggests the
rate of SCD related complications has risen which may be attributable to improved survivorship
(Perumbeti et al., 2018).

7
Neurological complications of SCD include symptomatic infarction (i.e., arterial
obstruction in the brain which impairs blood/oxygen flow and is accompanied by traditional
neurologic symptoms; also known as overt stroke or cerebrovascular accident [CVA]) and
intracranial hemorrhage (i.e., rupture of a blood vessel in the brain; Thust, Burke, & Siddiqui,
2014). These are serious complications, which affect approximately 24% of SCA patients by age
45 (Ohene-Frempong et al., 1998). The risk remains significant in the broader SCD population
(as compared to SCA specifically), with approximately 10% of individuals experiencing overt
stroke in their lifetime (Farooq & Testai, 2019). Unlike their SCD counterparts, a recent metaanalysis found that African Americans with SCT are not at increased risk for ischemic stroke
(Hyacinth et al., 2018).
Transcranial doppler (TCD) can be utilized to measure blood flow velocity. Overall,
those with an elevated TCD in the absence of blood transfusion are at the highest risk for initial
overt stroke although this risk can be reduced with the timely initiation of chronic blood
transfusions (Adams & Brambilla, 2005). It is recommended that TCD be utilized routinely in
SCD care (every 6 to 12 months) beginning at 24 months of age (Adams, 2005). Despite these
recommendations, one single-site study indicated that only 43% of board-certified pediatric
hematologists complied with this guideline (Raphael, Shetty, Liu, Mahoney, & Mueller, 2008).
The same researchers also found that patients with private insurance were three times more likely
to keep scheduled TCD appointments when compared to those with public insurance.
While strokes are often manifested by overt neurological symptoms such as numbness,
weakness, confusion, visual changes, or severe headache (National Center for Chronic Disease
Prevention and Health Promotion, Division for Heart Disease and Stroke Prevention, 2017),
individuals with SCD are also at an increased risk for silent stroke (also known as silent cerebral
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infarct; SCI). In such instances, patients do not experience overt neurological symptoms;
however, abnormalities are noted on magnetic resonance imaging (MRI; Kinney et al., 1999). On
MRI, SCI are typically visible as white matter hyperintensities (WMHs; van der Land, et al.,
2016). Although small WMHs are sometimes seen in healthy populations (Debette & Markus,
2010; Hopkins et al., 2006; Sachdev, Chen & Wen, 2008), the quantity and volume are often
exceptional in those with SCD, with the prevalence as high as 39.1% by age 18 (DeBaun et al.,
2012; Farooq & Testai, 2019; Wang et al., 2001). In both children and adults, SCI increases the
patient’s risk for subsequent SCI and/or overt stroke (Jordan et al., 2018; Pegelow et al., 2002).
Overt strokes tend to occur in the internal carotid and middle cerebral arteries in patients
with SCD (Adams et al., 1988; Pavlakis et al., 1988; Pegelow et al., 2002; Rothman, Fulling, &
Nelson, 1986; Schatz, Brown, Pascual, Hsu, & DeBaun, 2001; Switzer et al., 2006; Telfer et al.,
2011; Wang et al., 1998; Waterston, Brown, Butler, & Swash, 1990). Overall, the regions of the
brain distally served by the anterior and middle cerebral arteries (known as the border zones due
to decreased perfusion in these relatively distant areas; Mangla, Kolar, Almast, & Ekholm, 2011)
are the most commonly affected, including the deep white matter, basal ganglia, middle and
superior frontal gyrus, and dorsal parietal regions (Pavlakis et al., 1988; Powars et al., 1999). SCI
in the border zones are associated with low velocity blood flow, suggesting insufficient
oxygenation to the affected tissue (Ford et al., 2018). In the SCD population, infarct in the frontal
lobe is the most frequently affected location, found in up to 93% of patients with either silent or
overt stroke (Brown et al., 2000; Schatz et al., 2001). To date, literature has not examined
differences in stroke location in adults as compared to children; however, adults are more likely
to have a broader etiology which may include fat embolism or illicit substance use (Calvet et al,
2015). Collectively, overt strokes account for approximately 10% of all SCD deaths (Manci et
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al., 2003). Even without evidence of tissue damage, chronic cerebral blood flow dysfunction has
also been noted in adult SCD patients (Doepp, Kebelmann-Betzing, Kivi, & Schreiber, 2012).
Medical Treatments
Treatments for SCD include pain management, red blood cell transfusion, hydroxyurea,
Endari, and stem cell transplantation (also known as bone marrow transplant; Mayo Clinic Staff,
2019). Each of these treatments are discussed in greater detail below.
Pain management. As mentioned, one of the most common complications of SCD are
acute painful episodes which tend to become more frequent with age (Panepinto, Brousseau,
Hillery, & Scott, 2005). Similarly, adults with SCD tend to have higher rates of emergency room
visits when compared to pediatric samples (Wolfson, Schrager, Khanna, Coates, & Kipke, 2012).
The episodes are so common that the American Pain Society, American College of Physicians,
NHLBI, and the CDC’s National Center on Birth Defects and Developmental Disabilities have
each published guidelines for the use of analgesics with the SCD population. They all indicate
that SCD requires prompt treatment and recommend the use of opioids for severe pain. The use
of oral morphine has even been found to decrease the rate of hospitalization as well as the need
for intravenous medication (Paquin et al., 2019). In addition to these acute VOCs, many adults
with SCD also experience daily chronic pain (Smith et al., 2008). Alternatives to pharmacology
are available and effective to lessen SCD-related chronic pain. Interventions include prayer or
spiritual healing, acupuncture, massage therapy, meditation, self-hypnosis, relaxation training,
and cognitive behavioral therapy (Anie & Green, 2015; Chen, Cole, & Kato, 2004; Dinges et al.,
1997; Sibinga, Shindell, Casella, Duggan, & Wilson, 2006; Thomas, Dixon, Milligan, &
Thomas, 1999; Thomas, Wilson‐Barnett, & Goodhart, 1998; Williams & Tanabe, 2016).
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Transfusions. Red blood cell transfusion increases the number of circulating red bloods
cells by removing them from donor blood and transferring them to the recipient intravenously.
The benefits of red blood cell transfusion include temporary correction of anemia, improvement
of the blood’s ability to transport oxygen, reduction or prevention of sickling, and control or
prevention of vascular and tissue damage (Howard & Telfer, 2015). Blood transfusion also
reduces the risk of overt stroke; however, possible complications include infection and iron
overload, among others (Ballas, 2001; Ballas, Zeidan, Duong, DeVeaux, & Heeney, 2018;
DeBaun et al., 2014; Garraud et al., 2018; Harmatz et al., 2000; Talahma, Strbian, Sundararajan,
2014; Verduzco & Nathan, 2009). Chronic blood transfusions, every three to four weeks, are
common for those with elevated TCD which indicates a high risk for overt stroke. Excessive iron
in the blood may be controlled through chelation therapy (i.e., the removal of iron from the body
with the use of medication such as Jadenu; Allali, de Montalembert, Brousse, Chalumeau, &
Karim, 2017; Cohen & Martin, 2001; Kwiatkowski & Cohen, 2004).
Hydroxyurea. Hydroxyurea is an enteral chemotherapy medication which reduces the
occurrence of pain crises, acute chest syndrome, and the need for blood transfusions in patients
with SCD primarily by stimulating the production of HbF (Lanzkron, Rand, Haywood & Hassell,
2008; Voskaridou et al., 2010; Wong, Brandow, Lim, & Lottenberg, 2014). Higher rates of HbF
predict increased life expectancy in patients with SCA (Platt et al., 1994; Powars, Weiss, Chan,
& Schroeder, 1984; Voskaridou et al., 2010; Wong et al., 2014) and at least one study has
demonstrated improvement in survival associated with duration of hydroxyurea exposure
(Voskaridou et al., 2010). In 2002, the NHLBI issued seminal guidelines encouraging the use of
hydroxyurea for those with SCD. Despite these benefits and guidelines, a survey of adult SCD
providers indicated that the drug was prescribed for less than half of eligible patients (Lanzkron
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et al., 2008). This survey also indicated significant group differences with regard to provider
race, as providers who identified as Black had higher rates of eligible patients on hydroxyurea
than those identifying as White (94% vs 73%). The most frequent reasons endorsed by providers
for not prescribing the medication was related to lack of awareness of the drug and disagreement
regarding the benefits. Even when prescribed, adherence is often poor, which may be related to
delayed onset of symptoms following a missed dose as well as fear of long-term toxicity
(Brandow & Panepinto, 2010; Heeney & Ware, 2010). Current NHLBI (2014) guidelines include
the introduction of hydroxyurea as early as 9 months of age and continued use throughout the
lifespan regardless of clinical severity.
Endari. In 2017, the U.S. Food & Drug Administration (FDA) announced that a new
drug, Endari, was approved to treat the complications of SCD in patients age five years and
older. The generic agent is L-glutamine and while the drug’s mechanism of action is not
completely understood, it is believed to reduce oxidative damage to red blood cells (Niihara et
al., 2018). The treatment lowered the incidence of both pain crises and acute chest syndrome in a
clinical sample and decreased the number of hospitalization days (p = 0.005). Although there is
some additive benefit when used in conjunction with hydroxyurea, Endari comes at a much
higher cost than its predecessor (approximately $40,515 annually as compared to $1,700; The
Medical Letter, Inc., 2018). This is only the second drug approved for the treatment of SCD and
the first new treatment in almost 20 years.
Stem cell transplant. Stem cell transplants are the only potential cure for SCD and
involve intravenously replacing bone marrow in the recipient with healthy donor bone marrow
(NHLBI, n.d.). As part of the treatment, the recipient also receives chemotherapy and/or
radiation to destroy their own stem cells so that the donor cells may proliferate. It is difficult to
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find an appropriate donor and the potential complications are serious, including graft-versus-host
-disease (a complication in which the donor tissue begins to attack the host tissue) and even
death. As these risks are increased with older age, transplants are reserved for individuals
younger than 16 years old with particularly problematic symptoms. For these reasons, treatment
for SCD typically focuses on avoiding pain crises, symptom management, and prevention of
complications.
Neuropsychological Effects
In addition to the aforementioned physical symptoms, a range of neuropsychological
impairments have also been identified, even in individuals without a history of stroke (Wang et
al., 2001). Given the historically shortened lifespan in SCD, the literature has primarily focused
on pediatrics and limited research is available with adult participants. Therefore, the following
review will focus on the pediatric literature with a briefer discussion on the available adult
literature. Prior research has generally identified deficits in the following domains: cognition,
processing speed, learning and memory, academic achievement, visual motor integration,
attention, and EFs. The current literature review places a particular emphasis on EFs, which are
the primary area of consideration in this study.
Cognition. In the most commonly used measures of intellectual functioning, the Full
Scale Intelligence Quotient (FSIQ) is a composite score based on performance on multiple tasks
which measure various subskills (typically inclusive of verbal and nonverbal reasoning,
processing speed, and working memory)2. Due to the integration of these subskills into a single

Relevant findings related to processing speed and working memory, along with other aspects of
neuropsychological functioning, are discussed further in the subsequent sections.
2
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estimate of intellectual functioning (i.e., FSIQ), impaired performance in any of these areas will
reduce the broader FSIQ.
IQ testing has commonly been used as an overall measure of cognition in SCD research
and children with SCA have historically demonstrated significantly lower IQ scores when
compared to healthy controls (Armstrong et al., 1996; Brown, Armstrong, & Eckman, 1993;
Schatz et al., 2001; Schatz, Finke, Kellett, & Kramer, 2002). Children with SCA and history of
overt stroke demonstrated the greatest level of impairment, followed by children with history of
SCI, and then by children with no history of stroke (Cohen, Branch, McKie, & Adams, 1994;
DeBaun et al., 2012; Hogan, Pit-ten, Vargha-Khadem, Prengler, & Kirkham, 2006). Performance
on measures of IQ is negatively correlated with volume of WMHs (Schatz et al., 2002); however,
even in the absence of stroke, children with SCA continue to perform significantly below healthy
race, age, sex, and education matched controls (Berkelhammer et al., 2007; Kawadler, Clayden,
Clark, & Kirkham, 2016; Schatz et al., 2002), which is likely attributable to their chronic
hypoxic state as discussed above (Armstrong, Pavlakis, Goldman, Thompson, & Cuadra, 2010;
Kawadler et al., 2015). Further, the progression of WMHs was related to general cognitive
decline. Taken together, these results suggest that neuroanatomical changes in individuals with
SCD contribute to neuropsychological functioning.
Although the number of studies with adult patients is far smaller than those in pediatrics,
there is also evidence to suggest poorer general intellectual functioning in adults with SCA
regardless of history of stroke (Kugler et al., 1993). Vichinsky and colleagues (2010) conducted
the only large-scale study examining general cognitive functioning in adults with SCA. They
found that the mean FSIQ for patients with SCA was 90.47, as compared to 95.66 for age, sex,
and education matched healthy controls (p = .008). This reflects a difference of approximately 5
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IQ points, or 1/3 standard deviation, although some of these differences may be due to slower
processing speed (Crawford & Jonassaint, 2016). Mackin and colleagues (2014) utilized data
from Vichinsky’s research to examine the relationship between neuropsychological functioning
and frontal lobe cortical thickness and basal ganglia volumes. They found that participants with
SCA had thinner frontal lobe cortex as well as reduced basal ganglia and thalamus volumes
when compared to healthy controls. As a result, they adjusted data from Vichinsky et al., (2010)
for intracranial volume and found significant differences between those with SCA and healthy
controls based on Wechsler Adult Intelligence Scale – Third Edition (WAIS-III) FSIQ after
controlling for age, sex, and education level (adjusted mean, standard score of 91.2 for patients
vs 96.0 for controls [mean difference, −4.8]; p = .04). Lower IQ in the SCD population is also
consistent with findings of a meta-analysis which found that insults to white matter (which are
comprised of myelinated axons that facilitate quick communication between neurons) are
inversely associated with general cognitive functioning in non-SCD adult populations (Debette
& Markus, 2010; Vasquez & Zakzanis, 2015).
Processing speed. Processing speed refers to the time it takes to perceive and respond to
a stimulus or demand. Most processing speed tasks used in the SCD literature have utilized
psychomotor processing speed in particular (e.g., quickly matching numbers with symbols or
quickly scanning/marking complex arrays for specified targets). Some tests of processing speed
also measure accuracy by deducting points for errors. Overall, children with SCD tend to
demonstrate slower processing speed when compared to a normative population, with those with
SCA demonstrating the greatest impairment as compared to both SCD and healthy samples
(Smith & Schatz, 2016). Armstrong et al. (1996) also found significant differences on the
Wechsler Intelligence Scale for Children – Revised (WISC-R) Coding subtest (Wechsler, 1974;
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i.e., a measure that requires children to quickly pair numbers with geometric figures) when
comparing pediatric SCD patients with history of overt (p = .003) and silent stroke (p = .01), to
those with normal MRI. Van der land et al. (2016) found that higher volume of WMHs in
pediatric SCD patients was associated with reduced processing speed (as well as lower FSIQ;
however, as discussed, processing speed is a component of FSIQ).
With regard to research on processing speed in adults, Vichinsky et al. (2010) and
Crawford and Jonassaint (2016) both reported significantly lower (approximately 2/3 standard
deviation) processing speed in adults with SCA without history of CVA when compared to age,
sex, and education matched healthy controls - 11.46 (p < .001) and 10.77 (p = 0.02) points
respectively.3 This reflects the largest area of significant group difference (adjusted mean
standard score of 86.5 for patients vs 97.9 for controls [mean difference, -11.4]; p < .001;
Vichinsky et al., 2010). Again, when Mackin et al. (2014) adjusted data from Vichinsky et al.
(2010) for intracranial volume, results also documented significantly lower processing speed in a
patient sample when compared to healthy controls (adjusted mean, standard score of 87.2 for
patients vs 95.4 for controls [mean difference, −8.2]; p < .001). When these clinically and
statistically significant differences are accounted for, individuals with SCD see improved
performance in FSIQ scores, 3 points higher than those same controls (Crawford & Jonassaint,
2016; Stotesbury et al., 2018). Further, Vichinsky et al. (2010) did not find significant group
differences with regard to verbal (adjusted mean standard score of 92.14 for patients vs 96.04 for
controls [mean difference, -3.90]; p = .06) or nonverbal reasoning (adjusted mean standard score

Vichinsky et al. (2010) utilized a sample of SCA patients whereas Crawford and Jonassaint
(2016) utilized a more general sample of SCD patients. It should also be noted that different
measures were utilized to obtain these scores, Wechsler Adult Intelligence Scale – Third Edition
(WAIS-III) and CNS Vital Signs scores, respectively.
3
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of 90.75 for patients vs 95.10 for controls [mean difference, -3.96]; p = .06). These results
corroborate deficits in processing speed performance in adults with SCD, while suggesting that
lower FSIQ scores are best accounted for by slower processing speed. Jorgensen and colleagues
(2017) also published a study evaluating processing speed in an adult population. Participants
with genotypes typically associated with the most severe complications (e.g., HbSS) obtained a
mean T-score of 47.6 (SD = 14.5) on a measure of processing speed as compared to those with
moderate complications (e.g., HbSC), who obtained a mean T-score of 51.0 (SD = 13.4; both p =
.004). Again, this is consistent with findings of a meta-analysis of a general adult population
which found that WMHs are inversely associated with performance on measures of processing
speed (Debette & Markus, 2010); and that insult to subcortical white matter tracts is associated
with slower processing speed (Vasquez & Zakzanis, 2015). These differences in processing
speed have important implications for other aspects of neuropsychological functioning such as
academic achievement, EF, adaptive behaviors, as well as learning and memory.
Learning and memory. In simplest terms, learning and memory refers to the ability to
acquire and recall new information. The neuroanatomy of memory is complex and involves
various structures; however, memory involves two primary circuits. The first is the Papez circuit
(also known as the medial limbic circuit) which has been implicated in autobiographical and
explicit memory (Bauer, 2008; Preston & Eichenbaum, 2013; Schoenberg & Scott, 2011; Stucky,
Kirkwood, & Donders, 2014). The hippocampus is a central structure (where the circuit begins
and ends) that acts in coordination with the mammillary bodies, anterior thalamic nuclei, and
cingulate gyrus (Catani, Dell’Acqua & de Schotten, 2013). A second circuit, the lateral limbic
circuit, utilizes the amygdala as the central structure and has been implicated in emotional
memory and assigning emotional significance to stimuli. The lateral limbic circuit acts in
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coordination with the dorsomedial nucleus of the thalamus, orbitofrontal cortex, and uncinate
fasciculus (Stucky et al., 2014). Damage to either structure can result in memory impairment;
however, if damaged, each of these systems can accommodate one another to a large extent. In
addition, the dorsolateral prefrontal cortex (PFC) plays a role in memory consolidation and
organization while the cerebellum contributes to nondeclarative (also known as implicit)
memory (Preston & Eichenbaum, 2013; Schoenberg & Scott, 2011).
Deficits in learning and memory have been noted in the pediatric SCD population. On a
measure of rote verbal list learning, children with diffuse cerebral infarcts retained
approximately 20% less information than their healthy sibling controls despite several repetitions
(Schatz et al., 1999). Brandling-Bennett, White, Armstrong, Christ, and DeBaun (2003) found
similar challenges in list learning, while Watkins et al. (1998) noted significant group differences
on measures of visual memory and paired associate learning when children with SCD and a
history of frontal lobe infarct (either SCI or CVA) where compared to children with SCD
without stroke history and healthy controls.
Conversely, impairments in learning and memory have not been documented in
neurologically asymptomatic adults with SCA as compared to healthy demographically matched
controls (Vichinsky et al., 2010); however, this domain is understudied and only relatively
recently evaluated. Further, studies examining functioning in a more general SCD population
were not available. As such, continued research is necessary.
Academic achievement. Children with SCD face academic challenges and are more
likely to be retained (i.e., held back to repeat a grade), receive special education services, and
have a higher rate of absences when compared to peers (Dyson, Atkin, Culley, & Dyson, 2007;
Epping et al., 2013; Schatz, 2004). Fatigue and medical complications (e.g., infection, pain
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episodes) may account for at least a portion of these absences and subsequent loss of instruction
time. Learning difficulties in children with SCD include deficits in reading and mathematics
(Brown et al., 1993; Schatz et al., 2001). More specifically, left hemispheric overt stroke has
been associated with more global academic delays while those in the right hemisphere have a
stronger association with deficits in mathematics (Cohen et al., 1994). One longitudinal study
found a progressive annual decline in math achievement, with reading achievement deficits
remaining constant, even in pediatric patients with no neuroimaging abnormalities (Wang et al.,
2001). It has been hypothesized that these learning difficulties may be attributed to poor
sustained attention, organization, and problem-solving skills in both pediatric and adult patients
(Grattan & Eslinger, 1991). Some of these academic impairments may be buffered in individuals
from higher socioeconomic status (SES; i.e., social standing of an individual based on access to
resources) or with parents of higher educational attainment (Brown et al., 1993; Smith, Patterson,
Szabo, Tarazi, & Barakat, 2013). This may be attributed to factors such adequacy of school
district funding, familial access to private tutoring, learning materials or environments, educator
experience level, among other contributors (Aikens & Barbarin, 2008; Bradley, Corwyn,
McAdoo, & García Coll, 2001; Clotfelter, Ladd, & Vigdor, 2006; Orr, 2003).
Additional research on academic achievement such as rates of high school graduation and
completion of higher education in adults with SCD has not been published. Herron, Bacak, King,
and DeBaun. (2003) completed a brief analysis of high risk (due to frequent pain episodes and
history of overt stroke) 17-, 18-, and 19-year-olds receiving treatment at St. Louis Children’s
Hospital and found that only 15% were on target to complete high school. Further research is
needed to better understand the factors influencing academic achievement in adults with SCD.
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Attention. Attention refers to a collection of skills, which constitute the ability to
selectively maintain concentration on salient aspects of an experience while filtering out
distracters. Difficulties with attention have been noted in children with SCD and history of either
silent or overt stroke (Brown et al., 1993; Craft, Schatz, Glauser, Lee, & DeBaun, 1993; DeBaun
et al., 1998; Hijmans et al., 2011); similar to EFs, these difficulties are strongly associated with
overt stroke in the frontal lobe (Brown et al., 2000; Cohen et al., 1994; Schatz et al., 2001). As
silent strokes in those with SCD frequently occur in the frontal and parietal lobes, measures of
attention (and EFs) are commonly included in neuropsychological research for this population.
DeBaun et al. (1998) found that impaired performance on a measure of sustained attention, the
Test of Variables of Attention (TOVA), most strongly correlated with the presence of SCI.
Performance on the TOVA appropriately identified the presence of SCI in 86% of children with
SCA. In the educational setting, children with SCD often experience deficits with basic sustained
attention and concentration (Brown et al., 1993). Craft and her colleagues (1993) found
attentional deficits to be significantly more prominent in SCA pediatric patients when compared
to both those with diffuse lesions and their healthy sibling controls.
Research on attention in an adult SCD population is relatively limited; however,
Vichinsky et al. (2010) also found significant differences between healthy controls and adults
with SCA without history of neurological insult, on performance on a measure of visual attention
and scanning, (Test of Everyday Attention [TEA] 2-minute Map Search subtest) as well as the
TOVA.
Executive functions. EFs are a complex set of skills that allow individuals to
deliberately plan, direct, and monitor their own behavior (Stuss, 1992). The earliest research on
EFs arose from the study of patients with brain damage, particularly in the frontal lobe (Harlow,
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1868; Luria, 1972). Phineas Gage is a notable example, as he evidenced difficulty with
behavioral regulation following a severe workplace accident damaging his orbitofrontal brain
structures (Harlow, 1868). Through continued research, we have come to understand that EFs are
primarily orchestrated in the PFC, in coordination with many other brain regions (Alvarez &
Emory, 2006; Buchsbaum, Greer, Chang, & Berman, 2005; Damasio, Graff-Radford, Eslinger,
Damasio & Kassell, 1985; Stuss, 1992; Stuss et al., 1986). One meta-analysis found a moderate
positive correlation between EFs and both the volume and thickness of the PFC in a healthy adult
sample (Yuan & Raz, 2014). In addition to reduction in gray matter, the integrity of white matter
tracts linking the PFC and other regions also influences EF. Brinkman and colleagues (2012)
found a positive correlation between damage to the white matter of the frontal lobes bilaterally
and impaired performance on various measures of shifting attention, planning/organization,
working memory, and cognitive flexibility. Results from these and similar studies, have
converged to support EFs as orchestrated in the frontal lobe, and most often the PFC specifically.
A meta-analysis found a significant inverse relationship between WMHs and performance on
measures of EF (Debette & Markus, 2010). As such, it is reasonable to anticipate deficits in EF
in patients who both chronically and acutely experience insufficient blood flow to the primary
orchestrating regions.
EF is an umbrella term for many distinct yet complementary skills (Miyake et al., 2000).
In considering the diverse, yet related, nature of EFs, it becomes necessary to identify the
particular EFs examined in this study. From the larger study on cerebral blood flow in SCD, data
from several key EFs were available: inhibition (i.e., the ability to inhibit prepotent responses or
to refrain from an impulsive response in favor of another), working memory (i.e., the ability to
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mentally hold and manipulate information), and cognitive flexibility (i.e., the ability to switch
one’s attention between and within tasks).
Working memory. Working memory refers to the ability to mentally hold and manipulate
information (Blumenfeld, 2010). The neuroanatomy of working memory remains debated;
however, it appears to encompass several different brain regions which vary based on the type of
information processed (Eriksson, Vogel, Lansner, Bergström, & Nyberg, 2015). Barbey,
Koenigs, & Grafman (2013) studied patients with brain lesion and results indicated that the left
dorsolateral PFC is primarily implicated in manipulating both verbal and spatial sequencing
information (e.g., WAIS-III Letter-Number Sequencing subtest, Wechsler Memory Scale - Third
Edition [WMS-III] Spatial Span Backward subtest) while the right dorsolateral PFC was
implicated in verbally mediated quantitative reasoning (e.g., WAIS-III Arithmetic subtest)4.
Meta-analyses have also documented lateralized findings with the left PFC implicated in verbal
working memory tasks and the right PFC implicated in spatial tasks (Nee et al., 2012; Wager &
Smith, 2003). In addition to the PFC, the bilateral parietal lobes (right greater than left) play a
role in spatial working memory and are believed to assist with directing attention (Awh, Vogel,
& Oh, 2006; Nee et al., 2012). Cerebellar involvement has also been documented, which further
elucidates the communication that would be necessary in order to integrate these various brain
regions (Nee et al., 2012). Contributing to this support for working memory as a highly
collaborative process, disruption to the white matter pathways as part of normal aging has been
associated with working memory impairment (Charlton, Barrick, Lawes, Markus, & Morris,
2010).

Significant differences were not observed with regard to measures of auditory (WAIS-III Digit
Span Forward) and visual attention span (WMS-III Spatial Span Forward) suggesting that these
abilities are mediated by different neuroanatomical processes.
4
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Consistent with the complex neuroanatomical networks involved with working memory,
Baddeley’s model of working memory proposes interdependence of four components: the
phonological loop, the visuospatial sketchpad, the episodic buffer, and the central executive
(1996a; 2000; 2003; 2007).
The phonological loop is responsible for holding speech-based information and operates
most predominantly in the left hemisphere, especially the temporoparietal region and Broca’s
area (Paulesu, Frith, & Frackowiak, 1993; Jonides et al., 1998). Unless rehearsed, this
information will fade within seconds, and increased rehearsal improves the likelihood that the
information is accurately retained. The presence of the phonological loop is supported by an
increase in errors for phonetically similar letters and words, as well as denotatively similar
words, even in stimuli presented visually (Baddeley, 1996a; Conrad, 1964; Conrad & Hull,
1964).
The visuospatial sketchpad is the complementary component for visual and spatial
information (Baddeley, 2007). It operates in much the same way as the phonological loop with
rehearsal leading to memory storage; however, it is predominantly located in the right
hemisphere of the brain.
The episodic buffer integrates information across various sensory inputs including
phonological, visual, and spatial (Baddeley, 2000). The term episodic is utilized to denote that
these various pieces of information are integrated into a unitary representation and that for many
experiences, neither visual/spatial nor phonological data alone are sufficient to encapsulate the
memory.
The central executive refers to general processing capacity and is purely attentional,
incapable of storage (Baddeley, 2007). Baddeley utilizes Norman and Shallice’s model of the
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Supervisory Attentional System (SAS) to account for the central executive (1986). They propose
that behavior is controlled at two different levels. On the first are automatic behaviors, which
occur due to familiar habits. The other, the SAS, is a mechanism for overriding habitual
behaviors in situations that require it. In the model, individuals with damage to the frontal lobe
are assumed to also have damage to the SAS. They are able to act in familiar and habitual ways,
however, lack the ability to appropriately modulate their behaviors to the demands of the context.
The concept of the phonological loop has been the basis of many evaluations of working
memory in the pediatric SCD population (e.g., digit span), while the visuospatial sketchpad has
been less studied. In one study that evaluated both systems, children with SCD demonstrated
impairment in both verbal and visuospatial working memory (Smith & Schatz, 2016). The same
study found that although processing speed is decreased in patients with SCD, which limits the
rate of rehearsal, it does not appear to contribute to the observed deficits in working memory.
Hijmans and colleagues (2011) found significant deficits in visuospatial working memory,
although no such differences were found with verbal working memory when comparing a
pediatric SCD population to healthy SES-matched controls.
Vichinsky and colleagues (2010) provided the first study on working memory in an adult
SCA population. They did not include scores for each subtest; however, reported overall
performance on the WAIS-III Working Memory Index (WMI) to be significantly lower in SCA
patients without history of neurological insult when compared to demographically matched
controls (adjusted mean, standard score of 90.75 for patients vs 95.25 for controls [mean
difference, −4.5]; p = .03). Mackin and colleagues (2014) reported similar results when adjusting
data from Vichinsky et al. (2010) for intracranial volume (WAIS-III WMI adjusted mean,
standard score of 91.5 for patients vs 96.0 for controls [mean difference, −4.5]; p = .03).
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Inhibition. Inhibition, also known as inhibitory control, refers to the ability to resist a
prepotent response in favor of another (Hampshire, Chamberlain, Monti, Duncan, & Owen,
2010). The right anterior insula has been implicated in detecting cues to suppress a response
while the right inferior frontal cortex (also known as the ventrolateral PFC) has been implicated
as the area of primary activation while enacting the necessary inhibitory control (Aron, Robbins,
& Poldrack, 2004; Cai, Ryali, Chen, Li, & Menon, 2014; Levy & Wagner, 2011). Performance
on inhibitory tasks is reduced following prefrontal insults (e.g., overt stroke) in the general
population (Floden & Stuss, 2006), as well in the pediatric SCD population (Craft et al., 1993;
Christ, Moinuddin, McKinstry, DeBaun, & White, 2007). Even without apparent medical
complications, children with SCD show impaired inhibitory control (Hijmans et al., 2011).
Vichinsky et al. (2010) provides the only known assessment of inhibition in adults with
SCA and reports significant differences between neurologically asymptomatic patients and
healthy demographically matched controls (adjusted mean scaled score of 6.61 for patients vs
9.06 for controls [mean difference, −2.45]; p < .001) on the Delis–Kaplan Executive Function
System (D-KEFS) Color Word Interference Task, Trial 35. Studies examining functioning in a
more general SCD population were not available.
Cognitive flexibility. Cognitive flexibility refers to the ability to quickly and accurately
switch between rules or task demands (Dajani & Uddin, 2015). There is support for the primary
activation of the lateral PFC during tasks of cognitive flexibility (i.e., the Wisconsin Card
Sorting Test [WCST], D-KEFS; Blumenfeld, 2010; Buchsbaum et al., 2005; Yochim, Baldo,
Nelson, & Delis, 2007). Functional MRI (fMRI) studies have indicated more specific activation
of the ventrolateral PFC while participants are performing tasks measuring cognitive flexibility

5

See Methods section for a detailed discussion of this measure.
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(Dajani & Uddin, 2015). These findings are often reliable enough to differentiate healthy
controls from patients with frontal lobe lesions (Yochim et al., 2007).
Cognitive flexibility is comprised of two complementary subsystems: set shifting and
task shifting (Dajani & Uddin, 2015). Set shifting refers to the ability to process information
based on different rules within a task whereas task shifting refers to the ability to quickly shift
between tasks with different instructions (Dajani & Uddin, 2015; Konishi et al., 1998; Monsell,
2003). Task switching is conceptualized by Bunge and Zelazo (2006) as the most complex form
of cognitive flexibility. Although distinct concepts, task switching places greater demands on
one’s capacity for working memory as it requires that the individual remember separate rules for
each task (Dajani & Uddin, 2015). Aspects of inhibition are also implicated in cognitive
flexibility as the individual must possess the capacity to control more immediate, or habitual,
responses in favor of responses that would be consistent with the task demands (Davidson,
Amso, Anderson, & Diamond, 2006).
Research on cognitive flexibility in this population is less bountiful than other EFs.
Watkins and colleagues (1998) found that children with SCD and history of overt stroke had
significantly more perseverations when administered the WCST when compared to children
without history of overt stroke and healthy sibling controls. Brown et al. (2000) found that
children without history of overt stroke worked more quickly on a Trail Making task than did
children with either SCI or overt stroke history.
Adults with SCA and demographically matched controls performed similarly on the WCST;
however, significant differences were noted based on performance on the D-KEFS Trail Making
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Test Trial 46 (a test of visual attention, processing speed, and cognitive flexibility; Vichinsky et
al., 2010). Studies examining functioning in a more general SCD population were not available.
Sociopolitical Considerations
Historical Context. As has been the case for other diseases (e.g., syphilis, Tay Sachs),
research, treatment, and even acknowledgement of the SCD process are all reflective of social
and political climate. While the African people had long spoken of a debilitating disease marked
by intense pain episodes (Konotey-Ahulu, 1974), attention in the U.S. focused more on the
disease’s impact to productivity for slave owners (Phillips, 1999). This occurs alongside the
development of pseudoscience promoting the fallacy that Black individuals are resistant to pain
and thus require harsher beatings to gain compliance (Cartwright, 1851). Such behaviors were
representative of the normative social values of the time.
A demand for medical parity gained traction during the 1960s and ‘70’s when, civil rights
advocates brought SCD to the forefront and highlighted the significant health disparities. Indeed,
SCD became a focus within the civil rights movement. Activists of the time cited the reality that
most patients with SCA did not live beyond their teenage years (Scott & Castro, 1979; Wailoo,
2014). Despite the obvious toll on Black health and the disease’s early identification as
molecular in nature (Herrick, 1910), little research had been conducted to advance treatment for
these patients. This lack of research contributed to a life expectancy in the teenage years for
individuals with SCD (Scott & Castro, 1979; Wailoo, 2014); however, the Sickle Cell Anemia
Control Act of 1972 allocated federal funding toward the research, treatment and education of
SCD. While critical advancements were made in the years following this action, support soon
faded (Scott & Castro, 1979).

6

See Methods section for a detailed discussion of this measure.
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Health Disparities. To this day, individuals with SCD continue to face significant
disparities with regard to access to quality medical care as well as systemic racism. Despite their
chronic and debilitating pain, individuals with SCD are often viewed by hospital personnel as
time-consuming, illegitimate users of health care resources who are seeking prescription drugs
for illicit purposes (Aisiku et al., 2009; Alao, Westmoreland & Jindal, 2003; Jacob, 2001). These
perceptions contribute to negative provider attitudes, and ultimately negative healthcare
experiences for the patient (Carroll, Haywood, & Lanzkron, 2011; Shapiro, Benjamin, Payne, &
Heidrich, 1997). Although the prevalence of prescription drug abuse is almost doubled in White
individuals, opioids are more cautiously, more slowly, and less frequently prescribed for Black
patients (Armstrong, Pegelow, Gonzalez, & Martinez, 1992; Lazio et al., 2010; Vaughn, Nelson,
Salas-Wright, Qian, & Schootman, 2016). Remnants of Cartwright’s teachings smolder in the
field as a relatively recent study indicated one-third of physicians and medical students surveyed
believed that Black patients inherently experience less pain than their White counterparts
(Hoffman et al., 2016). When seeking emergency medical services, patients with SCD may wait
25 to 50% longer for treatment when compared to other patients and these results were also
significantly associated with identification as African American (Haywood, Tanabe, Naik,
Beach, & Lanzkron, 2013).
There exists a clear parallel between these modern experiences and the long-standing
inequity and even cruelty in healthcare for ethnic minorities in the U.S. (Baker et al., 2008; Byrd
& Clayton, 2001; CDC, 2015; Reverby, 2012; Gamble, 1997). A recent poll conducted by
National Public Radio (NPR), found that almost one-third of African Americans reported
experiences of discrimination in a healthcare setting (Neel, 2017). Similar studies have also cited
significant perceptions of racism when seeking medical treatment (Hatzfeld, Cody-Connor,
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Whitaker, & Gaston-Johansson, 2008; Nelson & Hackman, 2013; Strickland, Jackson, Gilead,
McGuire, & Quarles, 2001). African American patients have shared that, among other factors,
the expectation of racism during health care provision reduces trust in their physician and
subsequent help-seeking (Benkert, Peters, Clark, & Keves-Foster, 2006; Cuevas & O’Brien,
2017; Jacobs, Rolle, Ferrans, Whitaker, & Warnecke, 2006; Kennedy, Mathis & Woods, 2007),
and also contributes to increased subjective stress ratings, depression, and decreased quality of
sleep (Anderson, 2013; Grandner et al., 2012; Mezuk et al., 2010). Furthermore, this lowered
trust is associated with nonadherence - a challenge consistently documented in the SCD
population (Brandow & Panepinto, 2010; Reeves, Tribble, Madden, Freed, & Dombkowski,
2018; Teach, Lillis, & Grossi, 1998).
Critique and Need for Further Study
In comparison to the number of studies completed in the pediatric population, relatively
little research has focused on adult patients. This may be partially because of SCD’s history as a
pediatric condition due to the significantly shortened life spans of previous generations. As
individuals with SCD are now expected to live into their fourth and fifth decades, it is
increasingly important to expand upon the literature to reflect the needs of those afflicted by the
condition. Such data are necessary in order to accurately anticipate, prevent, or remediate any
neuropsychological deficits in this population.
Further, of those studies that have examined SCD in adults, much of this research has
rightly focused on understanding the biomedical underpinnings of the disorder (Vichinsky et al.,
2010). As the literature expands, it is also important to balance this increased knowledge by
examining the relationship between SCD and neuropsychological functioning. Of particular
importance to the daily functioning of these patients is an examination of the relationship
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between EFs and SCD in adults. As such, the current study was guided by the following research
questions and hypotheses:
Research Questions and Hypotheses
Consistent with the aforementioned significant group differences between healthy
controls and SCD patients observed in the pediatric literature, as well as data from the only
available study examining EFs in an adult SCA population, it is anticipated that analyses of the
data from the current study will also yield significant group differences on measures of EFs
when comparing an adult patient sample to healthy controls. The following research question and
hypotheses are offered:

Research Question: Are there differences in EFs when comparing adults with SCD to a sample
of healthy controls?
a. Hypothesis 1a. Patients with SCD will demonstrate significantly lower performance on a
task of working memory when compared to healthy controls.
b. Hypothesis 1b. Patients with SCD will demonstrate significantly lower performance on
an inhibition task when compared to healthy controls.
c. Hypothesis 1c. Patients with SCD will demonstrate significantly lower performance on a

task of cognitive flexibility when compared to healthy controls.
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Chapter 3: Methodology
Study Aim
Given previously identified deficits in EFs in children with SCD (Christ et al., 2007;
Craft et al., 1993; Hijmans et al., 2011), the primary aim of the current study was to examine the
EFs of working memory, inhibition, and cognitive flexibility in a population of adults with SCD
in comparison to healthy controls. The following section presents the specific procedures of the
current study. The research design, sample, recruitment, data collection, and data analyses for the
study are described.
Research Design
This quantitative, pre-experimental study utilized a cross-sectional, static group
comparison design and is part of a larger project being conducted at Children’s Hospital Los
Angeles (CHLA) on cerebral blood flow response to perturbations in oxygen tension in
individuals with and without SCD7. Investigators in the larger study primarily examined:
1. Whether resting cerebral blood flow and oxygen are within the normal range in SCD
patients,
2. Whether patients with SCD compensate appropriately for brief changes in inhaled
oxygen tension, and
3. Whether cerebral blood flow and responses to change in oxygenation correlate with
neurovascular and brain parenchymal changes on MRI.
Participants were identified from the CHLA patient population and their family members
and divided into three groups: those with SCD, those with non-sickle cell anemia, and healthy
controls. Inclusion criteria consisted of:

The primary investigator on this larger study was Dr. John C. Wood. Data collection for the
study began in 2013.
7
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1. At least 13 years of age to cooperate with blood draw and MRI,
2. Either gender,
3. Competent to follow instructions,
4. Informed consent obtained from participants over 18 years of age, or parent/legal
guardian for those under 18 years of age,
5. Assent obtained from participants under 18 years of age, and
6. HbSS, HbSC, or HbSβ0 thalassemia genotypes for those in the SCD group.
Exclusion criteria included:
1. Clinically documented prior overt stroke,
2. Any known illness that might compromise subject safety or data integrity, and
3. Known pregnancy.
In addition to a medical workup including MRI and blood draw, the participants
underwent neuropsychological evaluation to examine profiles of patients with SCD. Consistent
with the aforementioned areas of identified dysfunction in the SCD population, a standardized
battery was developed to assess these areas (see Table 1). The neuropsychological assessment
battery was administered in an outpatient setting by a neuropsychologist or students under her
supervision. Demographic data (e.g., birth history, education level, income, academic
achievement, etc.) were collected through a questionnaire as well as review of CHLA medical
records, if available.
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Table 1
Neuropsychological battery for larger study
Measure

Subtests/Trials

Wechsler Abbreviated Scale of
Intelligence - Second Edition
National Institutes of Health Toolbox
Wechsler Adult Intelligence Scale –
Fourth Edition
Rey Complex Figure Test and
Recognition Trial

Acronym

Domain

WASI-II

General Intellectual
Functioning

Pattern Comparison Processing Speed

NIH Toolbox

Coding,
Symbol Search

WAIS-IV

Copy

California Verbal Learning Test Second Edition & Children’s Version

Processing Speed

RCFT

Visual Motor
Integration

CVLT-II &
CVLT-C
Learning & Memory

Rey Complex Figure Test and Recognition
Trial

Immediate, Delay

Wechsler Adult Intelligence Scale – Fourth
Edition

Digit Span Forward

Behavior Rating Inventory of Executive
Function
Delis-Kaplan Executive Function System

RCFT

WAIS-IV

Auditory Attention
Span

BRIEF
Color-Word Interference Test, Trail
Making Test, Verbal Fluency

D-KEFS
Executive Functions

National Institutes of Health Toolbox
Wechsler Adult Intelligence Scale – Fourth
Edition
Behavior Assessment System for
Children - Second Edition
PROMIS Fatigue Scale

Dimensional Change Card Sort, Flanker
Inhibitory Control
Digit Span Backward

NIH Toolbox

WAIS-IV

BASC-2

Social-Emotional
Health

Note. that many psychometric measures assess more than one aspect of functioning. As such,
the primary domain is indicated; however, particular subtests and/or trials are delineated as
appropriate. The overall measure is bolded the first time it appears in the table. Detailed
information regarding the measures selected for the current study is discussed in the
Neuropsychological Protocol and Data Collection section of this paper.

Participants
The sample for the current study was obtained from data collected as part of the
aforementioned larger study. As the purpose of the current study was to expand upon the
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literature for adult patients, a subset of the larger study’s SCD patients were identified for
inclusion based on their age (18-45 years old). A subset of healthy controls 18- to 45-years of
age was also selected. Individuals above the age of 45 were excluded to be consistent with the
general life expectancy of SCD patients and to account for the increased likelihood of cognitive
changes due to confounding disease processes. (e.g., increased likelihood of CVA/SCI, increased
rates of both chronic and acute pain). The final sample consisted of 65 individuals (31 SCD and
34 control).
Recruitment
Recruitment and data collection were consistent with an application approved by the
Institutional Review Board (IRB) of Children’s Hospital Los Angeles (CHLA; IRB
Application/Protocol #11-00083) as well as the IRB of Pepperdine University Graduate School
of Education and Psychology, Psychology Division (IRB Application/Protocol #18-12-951).
Participants were recruited from the CHLA SCD patient population and invitations to participate
were also extended to their friends and family members. Letters explaining the study and
requesting both healthy and SCD subjects were either given to patients during their routine
examinations or mailed to the address in the electronic medical record. Participants were paid a
total of $200 for 2 days ($100 after completion of the neuropsychological testing and $100 after
completion of the medical workup which included a brain MRI, oxygen manipulation, and a
oxygen saturation sensor worn overnight).
Data Collection
Neuropsychological Protocol. As part of the larger study, participants completed a
battery of assessments in the areas of general cognition, attention, language, verbal and nonverbal learning and memory, processing speed, visuomotor construction, and social-emotional
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functioning. Given the aims of this study, scores from measures assessing working memory,
inhibition, and cognitive flexibility were analyzed (see Table 2).
Table 2
Neuropsychological trials and subtests analyzed
Measure

Domain

WASI-II

General Cognition

Measure

Trial

Executive Function

WAIS-IV

Digit Span (Backward)

Working Memory

D-KEFS

Color-Word Interference Test (Trial 3)

Inhibition

D-KEFS

Trail Making Test (Trial 4)

Cognitive Flexibility

Wechsler Abbreviated Scale of Intelligence – Second Edition (WASI-II). The WASI-II
is a brief screening measure of general intelligence. It is comprised of four subtests –
Vocabulary, Similarities, Block Design, and Matrix Reasoning – which are very similar to the
subtests of the same names on the full-length Wechsler Adult Intelligence Scale – Fourth Edition
(WAIS-IV) and the Wechsler Intelligence Scale for Children – Fourth Edition (WISC-IV). The
WASI-II was normed on a sample of 2,300 examinees ranging in age from 6 to 90 years
including 201 children and 182 adults who were administered both the WASI-II and either the
WISC-IV or WAIS-IV. General intellectual functioning is estimated as an FSIQ using these 4
subtests (FSIQ-4) on the WASI-II. Unlike the WAIS-IV, the WASI-II FSIQ-4 does not integrate
processing speed as a component of intellectual functioning and as a result is less impacted by
processing speed. For this study, the WASI-II was used to examine group differences with regard
to general intellectual functioning.
Wechsler Adult Intelligence Scale – Fourth Edition (WAIS-IV). The WAIS-IV as a
whole is designed to measure intellectual ability. The test was normed on a sample of 2,200
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individuals ranging in age from 16 to 90 years. These individuals were stratified by age, gender,
education level, ethnicity, and region. From the WAIS-IV, our study utilized the Digit Span,
Coding, and Symbol Search subtests.
Digit Span. Digit Span has been used widely in research to assess working memory. Digit
Span is comprised of three trials. During the first trial, the examinee is asked to repeat strings of
numbers of increasing length. This provides a measure of immediate auditory attention span.
During the second and third trials, the examinee is asked to repeat strings of numbers of
increasing length either in reverse order or sequentially (smallest to largest), respectively. Both
of these trials are measures of working memory, as they require that the examinee not only
briefly hold this information in mind, but also mentally manipulate the information based on the
demands of the task. The sequencing task adds the potential confound of number sequencing and
other cognitive processes, so the Digit Span Backward (DSb) task was selected to provide the
purest overall measure of working memory.
Delis-Kaplan Executive Function System (D-KEFS). The D-KEFS is comprised of 9
stand-alone tests, evaluating various EFs. The D-KEFS was standardized on a sample of 1,700
individuals, ages 8 to 89 years, who were selected to represent the U.S. population with regard to
demographic profiles. For this study, the D-KEFS provides data on the EFs of response
inhibition and cognitive flexibility. More specifically, the Color-Word Interference Test (CW)
and Trail Making Test (TMT) were selected for this purpose.
Color-Word Interference Test. To allow for greater differentiation between EFs and other
confounding variables, CW is comprised of four trials, which are largely modeled after the
classic Stroop test (Golden, 1978). The first trial requires the examinee to quickly identify the
color of an organized array of squares and primarily provides a measure of rapid naming. The
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second trial requires that the examinee quickly read the names of colors printed in black ink and
primarily provides a measure of word reading speed. The third trial requires that the examinee
inhibit the automatic response of reading a color name and instead name the color of ink the
word was printed in (e.g., the word orange printed in purple ink) and primarily provides a
measure of response inhibition in addition to the above-mentioned foundational skills.
Performance on this third trial was examined in data analyses. In the final trial, examinees are
asked to switch between identifying the ink color and reading the name of a color printed in a
contrasting color, which provides a measure of cognitive flexibility in addition to response
inhibition, rapid naming, and word reading speed.
Trail Making Test. Similar to CW, the TMT consists of five trials, which allow for a
greater degree of discernibility between EFs and other confounds. The first trial screens visual
scanning ability by asking the examinee to quickly mark only a select number in a large,
scattered array. The second and third trials evaluate letter and number sequencing, respectively,
by asking the examinee to sequentially connect either letters or numbers among a field both
characters. The fourth trial provides an estimate of cognitive flexibility by requiring the
examinee to quickly alternate or “switch” between connecting numbers and letters in sequential
order. Performance on this fourth trial was utilized for data analyses as a measure of cognitive
flexibility. The final trial is a measure of graphomotor speed and asks that the examinee quickly
connect a series of open circles by tracing along a dashed line as fast as possible while marking
each circle along the track.
Preliminary Analysis
All of the continuous independent, covariate, and dependent variables were examined by
assessing means, medians, standard deviations, and minimum and maximum scores. The data
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were examined for the presence of any outliers using the interquartile rule (IQR) with a 2.2
multiplier (Hoaglin & Iglewicz, 1987). There were no significant outliers found in the data set.
Categorical variables (i.e., age, gender, race) and ordinal variables (i.e., parental
educational levels and both childhood and current annual combined family income) were
examined by assessing frequencies.
Data Analyses
SPSS (Version 24) was employed to analyze the data collected. Data analyses included
descriptive, correlational, and inferential analyses. In order to determine potential significant
differences in estimated intelligence and demographic factors between SCD and control groups,
the groups were compared using either independent samples t-tests for continuous variables (i.e.,
age, FSIQ-4) or chi-square tests for categorical variables (i.e., gender, ethnicity, level of parental
education, income category)8. Given significant group differences related to current annual
combined family income (described in results), this variable was then incorporated as a covariate
during subsequent hypothesis testing. More specifically, in order to test hypotheses, a multiple
analysis of covariance (MANCOVA) was performed with group (SCD or control group) as an
independent variable, current annual combined family income as a covariate, and performance
on WAIS-IV DSb (Working Memory), D-KEFS CW Trial 3 (Inhibition), and D-KEFS TMT
Trial 4 (Cognitive Flexibility) as dependent variables.

While parental education and income can be considered continuous variables, the data
collection method utilized in the original study was based on reporting brackets of educational
achievement and income that were not equal across levels; therefore, these variables were treated
as ordinal.
8
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Chapter 4: Results
Description of Participants
The 65 total participants included 40 females (61.5%) and 25 males (38.5%). Their ages
ranged from 18 to 45 years (𝒙̅ = 28.11) and average intellectual functioning was within normal
limits (𝒙̅ = 95.65; see Table 3 for demographic characteristics of the combined groups). While
participants were not asked to identify their own race, they were asked to identify each of their
parents as either African American or Other. The majority of the participants indicated that at
least one of their parents identified as African American (87.3%).
Various SES factors were considered. Regarding maternal education level, the majority
of the sample indicated that their mother completed some college (27.4%), while others reported
less than 8 years (8.1%), less than 12 years (3.2%), high school (19.4%), associate degree
(4.8%), bachelor’s degree (17.7%), some graduate school (4.3%), or a graduate degree (14.5%).
Regarding paternal education level, equal numbers of participants indicated that their father
completed high school or some college (26.8%), while others reported less than 8 years (3.6%),
less than 12 years (3.6%), associate degree (3.6%), bachelor’s degree (7.1%), some graduate
school (5.4%), or a graduate degree (14.3%). The majority of the sample reported a childhood
annual combined family income of below $20K (35%), while smaller portions of the sample
indicated incomes of $20K-39K (25%), $40K-59K (22.5%), $60K-79K (12.5%), $80K-99K
(12.5%), and $100K or above (17.5%). Similarly, the majority of the sample reported a current
annual combined family income of $20-39K (29.1%), while smaller portions of the sample
indicated incomes of less than $20K (27.3%), $40-59K (16.4%), $60-79K (9.1%), $80-99K
(9.1%), and $100K or above (9.1%).
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Table 3
Demographic characteristics of the combined groups
𝒙̅ (SD)

Demographic
Age

28.11 (7.84)

FSIQ-4

95.65 (11.33)

Demographic

N

Frequency

Female

40

61.5%

Male

25

38.5%

At least one parent identified as African American

55

87.3%

Neither parent identified as African American

8

13.7%

Less than 8 years

5

8.1%

Less than 12 years

2

3.2%

High school degree

12

19.4%

Some college

17

27.4%

Associate degree

3

4.8%

Bachelor’s degree

11

17.7%

Some graduate school

3

4.3%

Graduate degree

9

14.5%

Less than 8 years

2

3.6%

Less than 12 years

2

3.6%

High school degree

15

26.8%

Some college

15

26.8%

Associate degree

2

3.6%

Bachelor’s degree

4

7.1%

Some graduate school

3

5.4%

Graduate degree

8

14.3%

14

35%

Gender

Parent Race

Maternal Education

Paternal Education

Childhood Combined Annual Family Income
Less than $20,000

(continued)

40
Demographic

N

Frequency

$20-39,000

10

25%

$40-59,000

9

22.5%

$60-79,000

5

12.5%

$80-99,000

5

12.5%

$100,000 or above

7

17.5%

Less than $20,000

15

27.3%

$20-39,000

16

29.1%

$40-59,000

9

16.4%

$60-79,000

5

9.1%

$80-99,000

5

9.1%

$100,000 or above

5

9.1%

Childhood Combined Annual Family Income

Current Combined Annual Family Income

Preliminary Descriptive Analyses
Data were initially assessed for frequencies (categorical variables), as well as means,
standard deviations, and minimum and maximum scores (continuous variables). Means and
standard deviations were computed for continuous variables (see Table 4 for between group
sample characteristics). There were no outliers identified using the IQR for outliers with a 2.2
multiplier.
Demographic Differences and Relationships
Independent samples t-tests were computed to determine whether there were significant
group differences with regard to age or FSIQ-4.
Age. Age was similar between the control (𝒙̅ = 28.74, SD = 8.07) and SCD groups (𝒙̅ =
27.42, SD = 7.67) and independent samples t-test revealed no significant differences between
groups with regard to age (t(63) = .67, p = .50). Levene’s Test was utilized to assess the
assumption of homogeneity of variance and was nonsignificant (F = .02, p = .90).
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FSIQ-4. Similarly, there were no significant differences with regard to FSIQ-4 between
the control (𝒙̅ = 96.62, SD = 13.07, p = .47) and SCD groups (𝒙̅ = 94.58, SD = 9.15), t(63) = .72,
p = .08. Levene’s Test was utilized to assess the assumption of homogeneity of variance and
results indicated nonsignificant differences in variance (F = 3.25, p = .08).
Chi square tests were utilized to assess whether there were significant group differences
with regard to categorical demographic variables (i.e., gender, race, parental education levels,
and both childhood and current annual combined family income).
Gender. Binary gender was utilized and coded as either female or male. The control
group was 61.8% female and 38.2% male while the SCD group was 61.3% female and 38.7%
male. There were no significant differences between groups with regard to gender, x2 (1, N = 65)
= .002, p = .97.
Race. While seven options for race (African American/Black, American Indian/Alaska
Native, Asian/Pacific Islander, Caucasian, Hispanic/Latino, Multiracial, Other) were included
within the questionnaire, reported race was then collapsed into two general options during
analyses for ease of computation and retention of power. Data were coded as either African
American or Other given the aforementioned overwhelming prevalence of the disease in the
African American population. Further, data were extrapolated based on the participants’ report of
their parents’ racial identity such that a participant was categorized as African American if they
endorsed having at least one parent who is African American (87.3%). Conversely, the
participant was coded as Other if they endorsed Other for both parents (12.7%)9. There were no
significant differences between groups with regard to binary race, x2 (1, N = 63) = .38, p = .54.

9

Data were not available for 2 participants.
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Maternal Education Level. The majority of the control group indicated maternal
education level of high school (28.1%), while less than 8 years (9.4%), less than 12 years (3.1%),
some college (25%), bachelor’s degree (15.6%), some graduate school (3.1%), and a graduate
degree (15.6%) were endorsed to a lesser degree10. The majority of the SCD group indicated
maternal education level of some college (30%) while less than 8 years (6.7%), less than 12
years (3.3%), high school (10%), associate degree (10%), bachelor’s degree (20%), some
graduate school (6.7%), and a graduate degree (15.6%) were endorsed to a lesser degree11. There
were no significant differences between groups with regard to maternal education level, x2 (7, N
= 62) = 6.74, p = .46.
Paternal Education Level. The majority of the control group indicated paternal
education level of some college (29%), while less than 8 years (16.1%), less than 12 years
(3.2%), high school (22.6%), bachelor’s degree (9.7%), some graduate school (3.2%), and a
graduate degree (9.7%) were endorsed to a lesser degree12. The majority of the SCD group
indicated paternal education level of high school (32%) while less than 8 years (8%), less than 12
years (4%), some college (24%), bachelor’s degree (20%), some graduate school (6.7%), and a
graduate degree (13.3%) were endorsed to a lesser degree13. There were no significant
differences between groups with regard to paternal education level, x2 (7, N = 56) = 5.20, p = .64.
Childhood Combined Annual Family Income. The majority of those in the control
group endorsed a childhood annual combined family income of less than $20K (36.7%), while
$20-39K (16.7%), $40-59K (10%), $60K-79K (13.3%), $80-99K (10%), and $100K and above

Data were not available for 2 participants.
A data point was not available for 1 participant.
12 Data were not available for 3 participants.
13 Data were not available for 6 participants.
10
11
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(13.3%) were endorsed to a lesser degree14. The majority of those in the SCD group endorsed a
childhood annual combined family income between $40-59K (30%), while less than $20K (15%)
$20-39K (25%), $60K-79K (5%), $80-99K (10%), and $100K and above (15%) were endorsed
to a lesser degree15. However, there were no significant differences between groups overall with
regard to childhood combined annual family income, x2 (6, N = 65) = 10. 87, p = .09.
Current Combined Annual Family Income. The majority of control participants
endorsed a current annual combined family income of between $20-39K (33.3%),16 while the
majority of those in the SCD group endorsed a current annual combined family income of less
than $20K (28%; see Figure
1). Additionally, only one
participant in the SCD
group endorsed income
between $80K-99K (4%),17
with none endorsing income
Figure 1

at or above $100K as
Current combined annual family income

compared to 4 participants
in the control group endorsing income between $80K-99K (13.3%) and 5 endorsing income at or
above $100K (16.7%). This resulted in statistically significant differences between groups with
regard to current combined annual family income, x2 (5, N = 55) = 13.52, p = .02. Therefore,
these differences were considered during subsequent analyses.

Data were not available for 4 participants.
Data were not available for 11 participants.
16 Data were not available for 9 participants.
17 A data point was not available for 1 participant.
14
15
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Table 4
Between group demographic characteristics
Control

SCD

̅ (SD)
𝒙

̅ (SD)
𝒙

p

Age

28.74 (8.1)

27.42 (7.7)

.50

FSIQ-4

96.62 (13.1)

94.58 (9.1)

.47

Demographic

Demographic

N

Frequency

N

Frequency

Gender

p
. 97

Female

21

61.8%

19

61.3%

Male

13

38.2%

12

38.7%

Race

. 54
At least one parent identified as African American

28

84.8%

27

90%

Neither parent identified as African American

5

15.2%

3

10%

Maternal Education

.47

Less than 8 years

3

9.4%

2

6.7%

Less than 12 years

1

3.1%

1

3.3%

High school degree

9

28.1%

3

10%

Some college

8

25%

9

30%

Associates degree

0

0%

3

10%

Bachelor’s degree

5

15.6%

6

20%

Some graduate school

1

3.1%

2

6.7%

Graduate degree

5

15.6%

4

13.3%

Paternal Education

. 64

Less than 8 years

5

16.1%

2

8%

Less than 12 years

1

3.2%

1

4%

High school degree

7

22.6%

8

32%

Some college

9

29.0%

6

24%
(Continued)
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Paternal Education

. 64

Associate degree

2

6.5%

0

0%

Bachelor’s degree

3

9.7%

1

4%

Some graduate school

1

3.2%

2

8%

N

Frequency

N

Frequency

Demographic
Childhood Combined Annual Family Income

p
.09

$0-19,000

11

36.7%

3

15%

$20-39,000

5

16.7%

5

25%

$40-59,000

3

10%

6

30%

$60-79,000

4

13.3%

1

5%

$80-99,000

3

10%

2

10%

$100,000 or above

4

13.3%

3

15%

Current Combined Annual Family Income

. 02

$0-19,000

8

26.7%

7

28%

$20-39,000

10

33.3%

6

24%

$40-59,000

3

10%

6

24%

$60-79,000

0

0%

5

20%

$80-99,000

4

13.3%

1

4%

$100,000 or above

5

16.7%

0

0%

Testing Assumptions
Data were analyzed to ensure all assumptions necessary for MANCOVA. The groups
are categorical and by definition independent of one another while the dependent variables are
continuous. Box’s Test of Equality of Covariance Matrices indicated homogeneity of covariance
(see Table 5). Kolmogorov-Smirnov’s Test of Normality indicated that the data regarding
working memory, D(61) = .16, p = .001, inhibition, D(61) = .15, p = .002, and cognitive
flexibility, D(61) = .16, p = .001 were not normally distributed. All three dependent variables
were transformed into a normal distribution by taking the logarithm with a base of 10 (Bland,
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Altman, & Rohlf, 2013). Analyses were computed utilizing both the original and transformed
variables (with the latter using a more cautious p value of .01; Manikandan, 2010). Levene’s Test
indicated nonsignificant differences in variance for working memory (F = .09, p = .77),
inhibition (F = .38, p = .54), and cognitive flexibility (F = .16, p = .69). Pearson’s correlation did
not indicate a statistical relationship between the covariate (current combined annual family
income) and the dependent variables (working memory, inhibition, cognitive flexibility);
however, there were moderate positive correlations between the dependent variables themselves
(see Table 6; Evans, 1996). More specifically, there were moderate positive correlations between
working memory and inhibition, r = .41, p = .001, working memory and cognitive flexibility, r =
.47, p < .001, and inhibition and cognitive flexibility, r = .51, p < .001. Tabachnick and Fidell
(2012) suggest that no correlation be above r = .90; therefore, this assumption has been met.
Table 5
Box’s Test of Equality of Covariance Matrices
Box’s M

6.64

F

1.03

df1

6

df2

16720.03

Sig.

0.402
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Table 6
Pearson correlations for covariate and dependent variables

Variable

Current Combined
Annual Family Income
r

p

Working Memory

-.03

.85

Inhibition

-.06

Cognitive Flexibility

.20

Working Memory
r

p

.65

.41

.001

.18

.47

< .001

Inhibition
r

p

.51

< .001

Current Combined Annual
Family Income

Dependent Variables
Performance on the measures of EF are reported as scaled scores which have a mean of
10 and a standard deviation of 3. Broadly average scores range from 7 to 13 with lower scores
indicating poorer performance and higher scores indicating better performance. Scores have the
potential to range from 1 to 19.
Working Memory. The control group performed in the average range with a mean score
of 10.85, standard deviation of 3.44, and range from 6 to 19 (see Figure 2). Of note, there were
two individuals in the control group who obtained a scaled score of 19 which placed their
performance at the 99.9th percentile, one individual who obtained a scaled score of 16 (98th
percentile), and one individual who obtained a scaled score of 15 (95th percentile.) The SCD
group also performed in the average range on the measure of working memory with a mean score
of 10.88, standard deviation of 3.19, and range from 6 to 18. There was one individual in the
SCD group who obtained a scaled score of 18 (99.6th percentile), one individual who obtained a
scaled score of 17 (99th percentile), one individual who obtained a scaled score of 16 (98th
percentile), and one individual who obtained a scaled score of 15 (95th percentile). Despite
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these above average scores, neither group contained statistically significant outliers. Overall, the
combined groups performed in the average range with a mean score of 10.86, standard deviation
of 3.29, and range from 6 to 19. As a result of the aforementioned distribution of scores, the data
were negatively skewed.

Figure 2
Working memory scaled score histogram

Inhibition. The control group performed in the average range with a mean score of
10.44, standard deviation of 2.36, and range from 3 to 13 (see Figure 3). The SCD group also
performed in the average range on the measure of inhibition with a mean score of 9.71, standard
deviation of 2.37, and range from 4 to 13. Overall, the combined groups performed in the
average range with a mean score of 10.10, standard deviation of 2.37, and range from 3 to 13.
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Figure 3
Inhibition scaled score histogram

Cognitive Flexibility. The control group performed in the average range with a mean
score of 10.44, standard deviation of 2.33, and range from 5 to 14 (see Figure 4). The SCD
group also performed in the average range on the measure of cognitive flexibility with a mean
score of 9.46, standard deviation of 2.30, and range from 5 to 13. Overall, the combined groups
performed in the average range with a mean score of 9.98, standard deviation of 2.35, and range
from 5 to 14.
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Figure 4
Cognitive flexibility scaled score histogram

Hypothesis Testing
The aim of the current study was to examine EFs in an adult SCD population in
comparison to a sample of healthy controls. Hypotheses were tested using a MANCOVA to
determine statistically significant differences between groups (SCD or control) on each of the
three EF outcome measures, while controlling for current annual combined family income (see
Table 7). Additionally, post-hoc analyses were used to also examine potential group differences
in EFs without controlling for income.
Working Memory. The first hypothesis postulated that there would be significant
group differences on the measure of working memory (hypothesis 1a), with the SCD group
performing lower than the SCD group. MANCOVA revealed no significant group differences
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with regard to performance on WAIS-IV DSb when accounting for current annual combined
family income, F(2, 48) = .20, p = .82, ηp2 = .01. Additionally, no significant group differences
were found even when current annual combined family income was not accounted for, F(2, 49) =
.002, p = .82, ηp2 = .008.
Inhibition. The second research hypothesis was that there would be significant group
differences on the measure of inhibition (hypothesis 1b), with the SCD group performing lower
than the SCD group. MANCOVA revealed no significant group differences with regard to
performance on D-KEFS CW Trial 3 when accounting for current annual combined family
income, F(2, 48) = .53, p = .60, ηp2 = .02. Additionally, no significant group differences were
found even when current annual combined family income was not accounted for, F(2, 49) = .68,
p = .51, ηp2 = .03.
Cognitive Flexibility. The third hypothesis postulated that there would be significant
group differences on the measure of cognitive flexibility (hypothesis 1c), with the SCD group
performing lower than the SCD group. MANCOVA revealed no significant group differences
with regard to performance on D-KEFS TMT Trial 4 when accounting for current annual
combined family income, F(2, 48) = 3.04, p = .06, ηp2 = .12. Additionally, no significant group
differences were found even when current annual combined family income was not accounted
for, F(2, 49) = 1.98, p = .15, ηp2 = .08.
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Table 7
Adjusted and unadjusted means for dependent variables

Domain

Adjusted

Unadjusted

̅ (SD)
𝒙

̅ (SD)
𝒙

Subtest
Control

SCD

p

Control

SCD

p

Working Memory

WAIS-IV DSb

10.96 (3.11)

11.19 (3.17)

.82

10.85 (3.44)

10.88 (3.20)

.99

Inhibition

D-KEFS CW Trial 3

10.71 (2.27)

10.05 (2.20)

.60

10.44 (2.36)

9.71 (2.37)

.51

Cognitive Flexibility

D-KEFS TMT Trial 4

10.51 (2.29)

9.51 (2.07)

.06

10.44 (2.33)

9.46 (2.30)

.15

Main Effect. In addition to analyzing group differences for each of the three EF outcome
measures, MANCOVA was also used to examine associations between the groups and three EF
outcome measures together. It showed no significant multivariate effect for working memory,
inhibition, and cognitive flexibility as a whole in relation to whether participants were SCD
patients or healthy controls, Wilks’ λ = .91, F(3, 46) = 1.52, p = .22, ηp2 = .09.
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Chapter 5: Discussion
The purpose of the current study was to examine EF in a sample of adults with SCD.
More specifically, this study examined the EFs of working memory, inhibition, and cognitive
flexibility in a patient sample compared to healthy controls. Given the relatively small body of
literature examining EFs in adults with SCD, this study aimed to contribute to a better
understanding of the neuropsychological profile of this population. Methodological limitations
are considered and suggestions for future directions are offered.
Summary of Results
In the current study, both the SCD and control groups performed in the solidly average
range across measures of EF. Further, there were no significant differences in performance on
measures of working memory, inhibition, or cognitive flexibility between individuals with SCD
and healthy controls, both with and without controlling for current combined annual family
income. Consistent with earlier research (Vichinsky et al., 2010), the SCD group also performed
within the average range with regard to general intellectual functioning, at approximately 1/3
standard deviation below the mean, which was not statistically significant when compared to the
control group, which performed approximately 2 IQ points higher.
Interpretation of Findings
To date, there have been very few studies examining neuropsychological outcomes in
an adult SCD population. This lapse comes alongside a tremendous increase in the life
expectancy of those with SCD, such that the group of disorders are no longer considered
pediatric conditions (Platt et al., 1994). Despite undeniable advancements in life-preserving
medical treatments, brain-behavior relationships warrant further examination in this population.
The current study sought to contribute to this need by examining EF in an adult SCD population;
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however, findings regarding general intellectual functioning are also notable with important
implications for treatment.
Executive Functions. Earlier literature has demonstrated significant differences in EF
functioning of children with SCD when compared to both healthy controls and normative data
(Brown et al., 2000; Hijmans et al., 2011; Smith & Schatz, 2016). More specifically, these
studies indicate that children with SCD function significantly below their typical peers in various
aspects of EF including working memory and inhibition (with cognitive flexibility being less
studied). While the deficits are more pronounced in children with history of CVA, they may also
be present in the absence of CVA, either with or without SCI (Brown et al., 2000).
Limited literature has documented clinically and statistically significant differences with
regard to EF when comparing adults with SCA to a sample of healthy controls (Vichinsky et al.,
2010; Mackin et al., 2014). When comparing the participant characteristics of the study
conducted by Vichinsky and colleagues with the current study, there are some limitations.
While Vichinsky does not report the mean age of participants, the majority of both patients and
healthy controls in the study conducted were over the age of 30. In the current study, the average
age of those in the SCD group was 27.42 years and 28.74 years for those in the control group.
This suggests a potentially younger cohort in the current study. With regard to sex (binarily
defined), in Vichinsky’s study, the control group was 63% female as compared to the control
group which was 49% female. Approximately 61% of participants across either group were
female in the current study. Due to differences in data collection methods, SES factors are more
challenging to compare. For example, education levels for the participant were not collected
(although data was collected regarding parental education level), while Vichinsky reported that
the majority of the patient sample completed more than a 12th grade education (64%) while 36%
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obtained less than a 12th grade education, which was similar to that observed in the control group
(68% vs 32%). All individuals enrolled in Vichinsky’s study self-reported their race as “African
American,” which is compared to 84.8% of controls and 90% of those in the SCD group in the
current study. Vichinsky et al (2010) did not provide detailed information regarding treatment
histories of participants. When administered at least two of the same subtests as were analyzed in
this current study (D-KEFS CW Trial 3 and TMT Trial 4 which measure inhibition and cognitive
flexibility, respectively), adults with SCD performed in the low average range, which was
significantly below their healthy counterparts (Vichinsky et al., 2010). With regard to working
memory, data were not published on WAIS-III18 DSb performance specifically; however,
Vichinsky et al. (2010) reported that adults with SCD performed marginally in the broadly
average range and approximately 1/3 standard deviation below healthy controls on the more
general WAIS-III WMI. These findings diverge from those obtained in the current study which
suggest that performance on measures of working memory, inhibition, and cognitive flexibility
are within the normative range in an adult SCD sample. However, the current sample represents
the broader SCD population (as compared to SCA specifically) which may account for some of
the differences in findings. Additionally, participants in the prior study utilized a sample with a
broader age range than the current study (19-55 vs 18-45 years) and recruitment also occurred
from 12 sites across the U.S. (rather than the single site recruitment in the current study). These
results appear to provide evidence that at least some aspects of EFs may remain intact in adults
with SCD although understanding of protective factors warrants further research as they may
reflect site-specific practices or benefits from more recent treatment protocols.

The current study utilized the more recently published WAIS-IV; however, earlier literature
utilized the WAIS-III.
18
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General Intellectual Functioning. With regard to general cognition, earlier studies have
documented significantly lower functioning in children with SCD when compared to healthy
controls (Armstrong et al., 1996; Bernaudin et al., 2000; Brown et al., 1993; Schatz et al., 2001;
Schatz et al., 2002). Typically, those with SCA (as compared to other forms of SCD) present
with the most pronounced impairment (Berkelhammer et al., 2007; Kawadler et al., 2016; Schatz
et al., 2002), especially in the presence of CVA although SCI may also have significant
deleterious effects (Cohen et al., 1994; DeBaun et al., 2012; Hogan et al., 2006). Pediatric SCD
studies support an inverse relationship between the volume of SCI and IQ - a finding which has
also been found in non-SCD adult populations (Debette & Markus, 2010; Schatz et al., 2002).
While the available literature is limited, the relationship between general intellectual functioning
and SCD come alongside research documenting increased risk of SCI with age (Kassim et al.,
2016). As a significant portion of individuals with SCD will experience stroke of either variety,
and even in the absence of neuroradiological findings adults with SCD may demonstrate
performance significantly below a healthy population, concern arises for the neuropsychological
functioning of the aging SCD population (Farooq & Testai, 2019; Kugler et al., 1993; OheneFrempong et al., 1998) who are more susceptible to stroke in general and as a result are at
increased risk for cognitive decline.
While it was not intended as a primary analysis, the current study also contributed
information toward understanding general cognitive functioning in adults with SCD. Participants
were initially screened for general intellectual functioning and results indicated that performance
was within the average range for both the SCD and control groups. Significant group differences
were not found. A likely explanation for the observed similarities between groups with regard to
general intellectual functioning relates to the selection of the test battery. Many studies
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examining neuropsychological functioning utilize measures of FSIQ which is partially comprised
of processing speed (Armstrong et al., 1996; Bernaudin et al., 2000; Brown et al., 2000; Mackin
et al., 2014; Vichinsky et al., 2010). The current study measured intellectual functioning utilizing
the WASI-II FSIQ-4 which provides an estimate based on verbal and nonverbal reasoning,
without incorporating processing speed. As many cognitive abilities are interdependent, slower
processing speed may also impact performance in other domains although to a lesser degree
(e.g., timing out on perceptual reasoning tasks). Slowed processing speed in adults with SCD has
been documented and there is evidence to suggest that controlling for processing speed accounts
for SCD versus healthy control group differences with regard to general intellectual functioning
(Crawford & Jonassaint, 2016). Vichinsky et al. (2010) noted several significant group
differences when comparing those with SCA to healthy controls (including an adjusted mean
FSIQ of 92.14 for their SCD group and 96.04 for controls); however, the largest discrepancy was
with regard to processing speed. As a result of data suggesting processing speed was the greatest
area of discrepancy between SCA and control groups in the prior study (Vichinsky et al., 2010)
and research suggesting that significant groups differences are not found with regard to general
cognition when processing speed is accounted for (Crawford & Jonassaint, 2016), findings
documenting significant differences may underestimate intellectual functioning. Consistent with
this notion, Vichinsky et al. (2010) did not find significant group differences with regard to
verbal or nonverbal reasoning.
Treatment Implications. Taken together, these findings indicate that what is known
regarding the pediatric neuropsychological profile of SCD may not directly apply to adults. The
understanding of the biological basis of SCD, and in turn, best practices for managing symptoms,
has developed considerably over the past several decades. Of note, the current study arrives
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nearly a decade later than the only known study examining EFs in adults with SCA - Vichinsky
and colleagues’ 2010 publication. It is possible that younger cohorts have been able to benefit
from earlier implementation of these best practices, which likely influences neuropsychological
outcomes by reducing the incidence of SCI, CVA, and hypoxia. While explanatory factors
remain unclear, there are likely treatment implications which are considered below.
In 1998, hydroxyurea became the first medication approved by the FDA for the
treatment of SCD, and at least one limited study has demonstrated improvement in survival
associated with duration of hydroxyurea use (Ault, 1998; Voskaridou et al., 2010). Along with
decreasing mortality, hydroxyurea reduces many of the most common complications associated
with SCD, including need for transfusions to prevent CVA (Voskaridou et al., 2010).
Hydroxyurea has been effective in reducing the risk of overt stroke in the SCD population and
strokes of either variety, in turn, have been associated with poorer cognitive functioning (Cohen
et al., 1994; DeBaun et al., 2012; Hogan et al., 2006; NHLBI, n.d.). Puffer, Schatz, & Roberts
(2007) more directly examined the relationship between hydroxyurea and cognitive functioning.
Pediatric patients with SCD who utilized hydroxyurea for at least one year were found to have
significantly higher general intellectual functioning when compared to those who were not using
the medication. Recent literature has demonstrated a direct correlation between processing speed
and loss of white matter integrity (Stotesbury et al., 2018). There is evidence in the pediatric
SCD literature to suggest that the use of hydroxyurea preserves the integrity of white matter,
although additional research in an adult population is necessary (Nottage, 2014). Despite these
benefits, hydroxyurea is underutilized in many settings, and estimates indicate that hydroxyurea
is only prescribed for less than half of eligible patients (Lanzkron et al., 2008). When prescribed,
adherence is often poor (Arjunan, Moss, Burns, & De Castro, 2018; Heeney & Ware, 2010).
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While younger adults are more likely to both understand the purpose of hydroxyurea and report
use of the medication, this is not true of older individuals who may also benefit (Sinha, Bakshi,
Ross, & Krishnamurti, 2017). Taken collectively, these findings suggest the cognitive deficits
documented in previous literature may be prevented through timely and consistent use of
hydroxyurea. CHLA utilizes early and aggressive hydroxyurea to the maximum tolerated dose
beginning at 9 months of age, which is consistent with the current guidelines issued by the
NHLBI. As noted above, these treatment guidelines have not been routinely adopted across
providers and the treatment protocols utilized at outside institutions, where earlier studies were
predominantly conducted, is unknown. As the current SCD sample was taken from the CHLA
patient population, the observed results suggest an early and aggressive treatment protocol likely
protects against EF deficits. Data regarding length of hydroxyurea use and adherence were not
collected in the current study which limits our ability to draw conclusions as to whether this
explanation accounts for the current findings. Additional research should examine relationships
between use of hydroxyurea, as well as the more recent Endari, and neuropsychological
functioning.
Limitations & Future Directions
Despite best efforts, there are limitations with the current study which should be
addressed in future research. To be consistent with literature documenting the average life
expectancy of an individual with SCD, participants in this current study were limited in age
range from 18 to 45 years. In addition to the health-related needs of the general older adult
population, individuals with SCD face significant damage to the body organs, tissues, and/or
bones due to insufficient blood flow (Thein, Igbineweka, & Thein, 2017). Most notably, overt
stroke remains a leading cause of both morbidity and mortality with recent estimates at 10% the
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SCD population and 24% of the SCA population experiencing CVA by the age of 45, which is
approximately three times higher than same-aged African Americans without SCD (Farooq &
Testai, 2019; Ohene-Frempong et al., 1998; Strouse et al., 2009). The risk of CVA increases
dramatically with age (with one estimate at 360/100,000 in individuals ages 13-34,
1,160/100,000 in patients age 35-64, and 4,700/100,000 in individuals age 65 and older; (Kassim
et al., 2016; Strouse, Jordan, Lanzkron, & Casella, 2009). Additionally, by the fifth decade, 73%
of patients in a cohort study had at least one form of irreversible organ damage which was
attributed to vasculopathy (Powars, Chan, Hiti, Ramicone, & Johnson, 2005). As a result of these
disease-related processes, it is possible that an older sample would yield significant group
differences.
Similarly, the current sample excluded patients with a history of CVA to avoid
confounding the SCD neuropsychological data with results more attributable to CVA itself. In
addition to CVA, 38% of children with SCD have experienced SCI by the time they reach
adulthood (Farooq & Testai, 2019). Although SCI may go undetected due to the lack of
traditional neurological symptoms, significant neuropsychological changes in non-SCD
populations have been documented (Debette & Markus, 2010). Previous research on SCD
documenting significant deficits in general intellectual functioning as well as various aspects of
EF may at least partially reflect slower processing speed as well as disrupted cognitive processes
reflective of CVA or SCI localization. Additionally, as knowledge regarding the clinical
management of SCD has grown over recent decades, it is possible that a younger cohort's
demonstration of cognitive functioning more consistent with healthy peers reflects the benefits of
newer treatment approaches (such as the early and aggressive use of hydroxyurea to the
maximum tolerated dose). However, without continued research, results from the current sample
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may be misleading given the relatively high prevalence of both SCI and overt stroke in the SCD
population. Further, there is a need to more closely examine the role of SCI on
neuropsychological functioning in this population utilizing imaging (e.g., MRI) data.
While this study utilized racial/ethnic data for each participant’s parents, data were not
coded for the racial/ethnic identity of the participant themselves and as a result participant race
was determined by whether either parent identified as African American. The vast majority of
the sample had at least one parent who identified as African American. Given the stated
disparities in medical care often faced by the SCD population, allowing opportunities for the
patient to report their own ethnic and/or racial identity preferences may also be an avenue to
demonstrate provider cultural awareness and interest, which may aid in engaging a population
with continuing healthcare disparities (Aisiku et al., 2009; Alao et al., 2003; Armstrong et al.,
1992; Lazio et al., 2010; Vaughn et al., 2016).
The current study did not indicate current income to be contributory with regard to EF,
and other factors of SES assessed were similar across groups (e.g., parental income, parental
education level, childhood combined annual income); however, EF has a well-documented
association with SES (Ardila, Rosselli, Matute, & Guajardo, 2005; Sarsour et al., 2011). As a
result, future studies should consider controlling for broader aspects of SES (particularly aspects
present during childhood which have a greater likelihood of interacting with brain maturation
processes, such as access to an adequate and nutritious diet, availability of books and other
stimulating developmental materials, or time spent caring for younger siblings outside of school
hours; Hackman, Gallop, Evans, & Farah, 2015; Lawson, Hook, Hackman, & Farah, 2016).
Additionally, data regarding parental education levels and income brackets were coded across a
high number of categories which resulted in many cells with fewer than five participants. As a
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result, the ability to draw statistical inferences may be limited by the small cell sizes within each
of these categories. Future studies with larger sample sizes or alternative coding methods may be
considered.
Similarly, the current sample was selected from the CHLA patient population and their
friends and family and, as a result, there may be site-specific confounds. More specifically, by
selecting participants from an active patient population, there is an inherent bias toward
individuals with access to healthcare and/or insurance coverage. As discussed above, individuals
without adequate access to healthcare are more likely to experience complications which may
make the current sample unrepresentative of those without access to healthcare (Wolfson et al.,
2012). In the absence of routine comprehensive care, adults with SCD may utilize emergency
services when symptoms become most pronounced without adequate preventative care. Wolfson
et al., (2012) cited support for this pattern of healthcare utilization as there was a lower
likelihood of inpatient hospitalization which indicated that needs may be better addressed in a
less acute setting. Access to, and utilization of, comprehensive care and the relationship to
neuropsychological functioning should be further evaluated in future studies.
There are also inherent challenges in evaluating EFs (particularly in medical populations
who may experience high levels of pain, fatigue, or stress). First, task impurity must be
considered. By definition, EFs are a network of cognitive skills that rely on one another
(Baddeley, 1996a; Baddeley, 1996b; Baddeley, 1998; Miyake, Emerson, & Friedman, 2000).
Given the interconnectivity, many tasks will place demands across EFs, as well as other abilities.
For example, basic attention, visual processing, motor speed, and numerical awareness have the
potential to confound results.

63
If EFs are able to be isolated, there remains the question of whether or not the findings of
standardized assessment are ecologically valid (Barkley & Murphy, 2011). In the clinical setting,
test administration generally occurs in a quiet, one-to-one, non-distracting room. Seldom does
this accurately reflect the challenges an individual is likely to face in their natural environments.
This raises the question of whether performance on these tasks provide meaningful information
about everyday functioning. Further, prior research indicates that the performance-based
measures commonly utilized to evaluate EF in the clinical setting (e.g. WCST, Stroop test,
Tower of London) may not correlate with standardized report of symptoms in other settings,
suggesting that different constructs may be reflected with each measurement (Toplak, West, &
Stanovich, 2013). In a clinical setting, performance on measures of EF can be supplemented with
collateral information (e.g., the BRIEF) for comprehensiveness (Isquit, Roth, & Gioia, 2013). In
addition to their utility in providing a more wide-ranging account of symptoms, these reportbased measures also provide opportunities to measure aspects of EF that are less amenable to
performance-based testing (e.g., organization, initiation).
Despite these limitations, prior research on EFs in adults with SCD has been sparse and
this study is among the first to examine neuropsychological functioning in an adult SCD sample.
Additional research is necessary to critically examine whether profiles are similar across
geographic sites and across patient presentations (e.g., age groups, genotypes, treatment
histories). Understanding the neuropsychological profile of SCD, including differences in care
needs for pediatric and adult samples, will allow more informed treatment planning, prevention
efforts, and remediation as necessary. Further, expanding on this literature provides an
opportunity to begin to adjust the long-standing history of disparities in medical care often faced
by African Americans.
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Literature Table

Author(s)

Allen, Anderson,
Rothman, & Bonner

Anie & Green

Armstrong Pavlakis,
Goldman, Thompson, &
Cuadra

Methodology &
Sample

Psychometric Measures

Executive
functioning and
health-related quality
of life in pediatric
sickle cell disease

Cross-sectional study
in which 45 children
with SCD aged 8 to
16 years old as well
as their caregivers
completed measures
of quality of life as
well as executive and
psychosocial
functioning.

Pediatric Quality of Life
Inventory (PedsQL),
Behavior Rating
Inventory of Executive
Functioning (BRIEF),
Wechsler Abbreviated
Scale of Intelligence
(WASI), Parent
Experience of Child
Illness (PECI), Visual
Analog Pain Scale,
Hollingshead TwoFactor Index of
Socioeconomic Status

2005

Psychological
complications in
sickle cell disease

Literature review
with a focus on
psychological coping,
quality of life, and
neuropsychology.

2010

Neurocognitive
function in sickle cell
disease: Have we
been missing
something?

Year

2017

Title

Editorial

N/A

N/A

Outcomes

Relevant Findings

Quality of life

Controlling for age, pain, and SES, EF was
found to be positively correlated with child- and
parent-reported quality of life among children
with SCD.

Psychological
complications

With regard to the neuropsychological profile,
SCD is associated with impaired verbal
reasoning, visual-motor integration, attention,
and EFs which are dependent on location of both
overt and silent stroke (although to a lesser
degree in the latter).

Neurocognitive function

The author provides a very brief and general
overview of the neurocognitive outcomes for
those with SCD and calls for action to consider
the role of SCD related complications when
evaluating academic and vocational achievement
(as compared to attributing any impaired
performance to SES factors).
(Continued)
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Author(s)

Baker et al.

Brown et al.

Cahill et al.

Year

Title

Methodology &
Sample

88

Psychometric Measures

Outcomes

Relevant Findings

Literature review
based on the
American Medical
Association (AMA)'s
invitation to a panel
of experts to review
and analyze the
historical roots of the
black-white divide in
U.S. medicine.

N/A

Segregation, bias, and
exclusion against African
American physicians and
their patients.

There is a history of discrimination and
exclusion against Black physicians which
continues to impact Black physicians and their
patients.

2000

Neurocognitive
functioning and
magnetic resonance
imaging in children
with sickle cell
disease

Cross-sectional study
in which 63 children
and adolescents with
SCD underwent
neuropsychological
assessment after
referral by
investigators due to
concern for learning
problems and
adjustment
difficulties.

Wechsler Intelligence
Scale for Children-III
(WISC-III), WoodcockJohnson
Psychoeducational Test
Battery: Tests of
Achievement-Revised
(WJ-R), Cancellation A's
Task, Trail Making Test,
Boston Naming Test,
Rapid Automized
Naming (RAN), Purdue
Pegboard, Child
Behavior Checklist
(CBCL), Vineland
Adaptive Behavior
Scales

Neurocognitive function

Children with history of either overt or silent
stroke demonstrate differences from their peers
with regard to attention and EF. These deficits
are attributed to frontal lobe dysfunction.

2019

Sickle cell trait and
cognitive function in
African Americans:
The reasons for
geographic and racial
differences in stroke
(REGARDS) cohort

Longitudinal study in
which 7,743 Black
and White
individuals (583 with
SCT) with a mean
age of 63 underwent
psychological
assessment.

Neurocognitive function

Individuals with SCT are more likely to have
hypertension. In regard to the
neuropsychological screening, those with SCT
showed little change over time in word list
learning and recall, however, processing time
slowed with age and this affected performance
on timed tasks.
(Continued)

2008

African American
physicians and
organized medicine
1846-1968

Six-Item-Screener (SIS)
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Author(s)

Christ, Moinuddin,
McKinstry, DeBaun, &
White

Crawford & Jonassaint

DeBaun et al.

DeBaun et al.

El-Haj & Hoppe

89

Title

Methodology &
Sample

2007

Inhibitory control in
children with frontal
infarcts related to
sickle cell disease

Cross-sectional study
in which 52 children
ages 6 to 18 years
underwent
neuropsychological
assessment. Those in
the clinical group
were diagnosed with
SCD.

Stimulus-response
reversal inhibitory task

2016

Adults with sickle
cell disease may
perform cognitive
tests as well as
controls when
processing speed is
taken into account: A
preliminary casecontrol study

Cross-sectional study
in which 31 patients
with SCD (mean age
of 33) and 17
controls (mean age of
36) underwent
neuropsychological
assessment.

CNS Vital Signs, Stroop
test and unspecified
measures of memory,
finger tapping, symbol
digit coding, shifting
attention, and continuous
performance

2012

Silent cerebral
infarcts: A review on
a prevalent and
progressive cause of
neurological injury in
sickle cell anemia

Literature review

1998

Cognitive screening
examinations for
silent cerebral
infarcts in sickle cell
disease

Cross-sectional study
in which 28
individuals with SCD
ages 7 to 21 years
underwent
neuropsychological
evaluation.

Year

2018

Newborn screening
for SCD in the USA
and Canada

Literature review

Psychometric Measures

Outcomes

Relevant Findings

Inhibitory control

Children with SCA and frontal infarcts made
significantly more errors in an inhibitory control
task than children with SCA without history of
infarct.

Processing speed

Results corroborated earlier studies which found
that there is at least a 10-point deficit in
processing speed among SCD patients, however,
when differences in processing speed are
accounted for, those in the SCD group performed
as well as controls on various cognitive tasks.

N/A

Neurological injury

Risk for silent stroke is greatest in childhood.
Individuals with overt stroke generally have the
most impaired cognitive skills, followed by
individuals with silent stroke, then individuals
with no stroke history.

TOVA, WCST, CVLTC

Attention & EF

Screening for attention and EF were the most
reliable in identifying patients with history of
silent stroke.

Newborn screening

Newborn screening for SCD has been in place
across all 50 states since 2006. This has
improved the prognosis for individuals with
SCD through timely access to early intervention
services and prophylactic treatment. The authors
note that there are few studies that have
evaluated the long-term health outcomes in
adults with SCD.
(Continued)

N/A
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Author(s)

Gaston et al.

Hijmans et al.

Jacobs, Rolle, Ferrans,
Whitaker, & Warnecke

Jorgensen et al.

Kassim et al.

Title

Methodology &
Sample

1986

Prophylaxis with oral
penicillin in children
with sickle cell
anemia: A
randomized trial

Randomized, doubleblind, placebocontrolled clinical
trial examined
whether
administration of oral
penicillin would
reduce the incidence
of septicemia in
children with SCA
under the age of 3.
105 children received
the drug while 110
children received a
placebo.

2011

Neurocognitive
deficits in children
with sickle cell
disease: A
comprehensive
profile

2006

Understanding
African Americans’
views of the
trustworthiness of
physicians

2017

Disease severity and
slower psychomotor
speed in adults with
sickle cell disease

Cross-sectional study
in which 88 adults
with SCD underwent
neuropsychological
screening as well as a
blood draw.

2016

Silent cerebral
infarcts and cerebral
aneurysms are
prevalent in adults
with sickle cell
anemia

Cross-sectional study
in which 60 adults
with SCA underwent
neuroimaging using
MRI as well as
magnetic resonance
angiography (MRA).

Year

Cross-sectional study
in which 41 children
with SCD and 38
SES-matched
controls underwent
neuropsychological
evaluation.
Focus groups were
conducted at 2 sites
(a hospital and a
community advocacy
organization).
Participants were all
African American
and included 32
women and 34 men.

90

Psychometric Measures

N/A

WAIS-III, WISC-III,
Stop task, Tower of
London, N-back task,
Beery-Buktenica
Developmental Test of
Visual-Motor Integration
(Beery VMI)

N/A

Digit Symbol
Substitution Test
(DSST)

N/A

Outcomes

Relevant Findings

Septicemia

Children with SCA have an increased
susceptibility to bacterial infections.
Prophylactic oral penicillin was effective in
reducing the incidence of infection by 84%. The
authors concluded that those screened for SCD
during the neonatal period should begin
prophylactic penicillin by 4 months of age.

Neurocognitive function

SCD was associated with lower IQ scores and
more than 1 in 3 children with SCD had a FSIQ
below 75. Deficits were also noted in visuomotor functioning and EF.

African Americans’
distrust in healthcare

Factors contributing to African Americans’
distrust in physicians include a lack of
interpersonal and technical competence,
perceived quest for profit and expectations of
racism and experimentation during routine
provision of health care. Distrust inhibits careseeking and may lead to nonadherence.

Processing speed

Impairment in psychomotor speed was indicated
with no significant correlation related to history
of stroke or severity of anemia. Those with more
severe genotypes had more slowing than those
with moderate genotypes. *Note: The authors
state that there is impairment although the Tscores are in the average range.

SCI, aneurysm

SCI was found in 53% of the participants. Adults
with SCA also have a higher prevalence of
cerebral aneurysm than would be expected in
healthy individuals (9% observed).
(Continued)
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Author(s)

Kawadler et al.

Kawadler et al.

Kennedy, Mathis, &
Woods

Kinney et al.

Mackin et al.

Title

Methodology &
Sample

2016

Intelligence quotient
in paediatric sickle
cell disease: A
systematic review
and meta-analysis

A meta-analysis was
conducted utilizing
articles with a
pediatric SCD
population, MRI
information, and a
Weschler IQ.
Ultimately, 19
articles were included
and compared 3
groups: stroke vs
SCI, SCI vs no SCI,
and no SCI vs
healthy controls.

2015

White matter damage
relates to oxygen
saturation in children
with sickle cell
anemia without silent
cerebral infarcts

Cross-sectional study
in which 25 children
with SCA and 14
age- and racematched controls
underwent MRI.

2007

African Americans
and their distrust of
the healthcare
system: Healthcare
for diverse
populations

Historical perspective
on African Americas’
distrust of the
healthcare system.

1999

Silent cerebral
infarcts in sickle cell
anemia: A risk factor
analysis

Longitudinal study in
which 42 children
with SCD and no
known history of
CVA underwent
medical workup.

Neuroimaging
abnormalities in
adults with SCA

Cross-sectional study
in which 120patients
with SCA and 33
healthy controls
underwent
neuropsychological
assessment and
medical workup.

Year

2014
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Psychometric Measures

Outcomes

Relevant Findings

Full-Scale IQ

Children with stroke had an IQ of approximately
10 points lower than those with SCI, those with
SCI had an IQ approximately 6 points lower than
those with no SCI, and patients with no SCI had
an IQ approximately 7 points lower than healthy
controls. Children with SCD and no apparent
MRI abnormality have significantly lower IQ
than healthy controls.

N/A

White matter
abnormalities

There are significant white matter abnormalities
even in asymptomatic children diagnosed with
SCA. These abnormalities are taken as evidence
for the effects of chronic hypoxia on the central
nervous system.

N/A

African Americans’
distrust in healthcare

African Americans are often hesitant to
participate in biomedical research due to
historically rooted mistrust.

SCI

Children with history of seizures were 15x more
likely to have SCI. Lower hemoglobin level was
among other medical factors associated with
higher rates of SC. Elevated WBC were also
associated with SCD.

Neurocognitive function,
neuroimaging findings

Individuals with SCA have thinner frontal lobe
cortex and reduced basal ganglia and thalamus
volumes compared to healthy controls. Reduced
volume of the basal ganglia and thalamus were
significantly associated with lower performance
IQ, perceptual organization, and working
memory scores; however, frontal lobe cortex
thickness was not significantly associated with
any cognitive measures.
(Continued)

Any Weschler
intelligence scale (e.g.,
WASI, WISC, or WAIS)

N/A

WAIS-III
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Author(s)

Year

Title

Methodology &
Sample
230 patients with
SCA participated in a
randomized, placebocontrolled, doubleblind, phase 3 trial,
Longitudinal study in
which 4,082 patients
with SCD were
followed for an
average of 5.2 years
to assess age-related
prevalence and
incidence of CVA.

Niihara et al.

2018

A phase 3 trial of Lglutamine in sickle
cell disease

Ohene-Frempong et al.

1998

Cerebrovascular
accidents in sickle
cell disease

2019

Oral morphine
protocol evaluation
for the treatment of
vaso-occlusive crisis
in paediatric sickle
cell disease

Retrospective chart
review of patients
with SCD who
sought medical care
due to pain crises.

2016

Emergency
department
utilization by
Californians with
sickle cell disease,
2005-2014

Retrospective chart
review of patients
with SCD who
presented to the
emergency
department.

2002

Longitudinal changes
in brain magnetic
resonance imaging
findings in children
with sickle cell
disease

Longitudinal study in
which 266 children
and adolescents with
SCD underwent
MRI.

Guidelines for the
management of the
acute painful crisis in
sickle cell disease

Medline was
searched via PubMed
from 1965 to 2001 to
identify
hematologists with a
known interest in
SCD. They were then
contacted and invited
to submit guidelines
for the management
of sickle cell pain.

Paquin et al.

Paulukonis et al.

Pegelow et al.

Rees et al.

2003

92

Psychometric Measures

Outcomes

Relevant Findings

N/A

Pain crises

L-glutamine (brand name Endari) was effective
in reducing pain crises, acute chest syndrome,
and hospitalization days.

N/A

CVA

Overall, individuals with SCD have higher rates
of CVA. More specifically, those with SCA had
the highest rates followed by other forms of
SCD.

N/A

Hospitalization rate

The use of oral morphine was effective in
decreasing the need for hospitalization and
intravenous medication.

N/A

Emergency department
utilization rates

The study examined emergency department
utilization in California with SCD. 9/10 patients
were treated and released during the span of the
study; The average number of ED visits was 2.1
visits per year.

Neuroimaging findings

Researchers report that most lesions in girls
occurred before age 6, whereas boys remained at
risk until age 10. Overt stroke was less likely to
be found in the frontal or parietal cortex than
silent strokes. Children with SCI had an
increased incidence of new overt stroke and new
or more extensive silent stroke.

N/A

N/A

Pain

Guidelines were established to provide a basic,
minimum standard of care for patients with SCD
experiencing pain crises. Suggestions include
rapid admission to the hospital, analgesics within
30 minutes of arrival, and ruling out serious
complications such as infection, acute chest
syndrome, or neurological events.
(Continued)
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Author(s)

Routhieaux, Sarcone, &
Stegenga

Schatz, Brown, Pascual,
Hsu, & DeBaun

Schatz, Finke, Kellett,
& Kramer

Year

2005

2001

2002

Title

Neurocognitive
sequelae of sickle
cell disease: Current
issues and future
directions

Poor school and
cognitive functioning
with silent cerebral
infarcts and sickle
cell disease

Cognitive
functioning in
children with sickle
cell disease: A metaanalysis

Methodology &
Sample

93

Psychometric Measures

Literature review to
identify areas for
future research

N/A

Cross-sectional study
in which 19 children
with SCA and history
of SCI, 45 children
with SWCD and no
history of SCI, and
18 healthy sibling
controls underwent
neuropsychological
screening battery as
well as medical
workup.

Boston Naming Test,
Cancellation of A’s,
CVLT-C, Differential
Abilities Scale (DAS),
Judgment of Line
Orientation, Rapid
Automized Naming,
Peabody Picture
Vocabulary Test
(PPVT), Purdue
Pegboard, TOVA, Trail
Making Test, Wide
Range Assessment of
memory and Learning
(WRAML), WJ-R, Word
Fluency

Meta-analysis of
studies of cognition
in SCD to determine
the size of any
statistical difference
between children
with SCD and
controls.

British Abilities Scale
(BAS), Cancellation of
Recurring Figures Test,
DAS, Detroit Test of
Learning Aptitude-2,
Goodenough-Harris
Drawing Test, Kaufman
Assessment Battery for
Children (K-ABC),
Luria Nebraska
Neuropsychological
Battery for Children,
Matching Familiar
Figures Test, StanfordBinet Intelligence Test
(S-B), VMI, WAIS,
WCST, WISC, WISC-R,
WISC-III, WMS

Outcomes

Relevant Findings

Neurocognitive function

Overt stroke and SCI are both major
complications of SCD. Stroke, including silent
stroke, is associated with decreased IQ, math
achievement, verbal abilities, and visual-motor
integration. While the author believes care is
commonly sought for the physical symptoms of
SCD, they argue that this is not the case when it
comes to neurocognitive effects.

Neurocognitive function

Children with SCI had twice the rate of school
difficulties as children without them. Eighty
percent of SCI cases had clinically significant
cognitive deficits, whereas 35% had deficits in
academic skills. Children with SCI show high
rates of poor educational attainment, cognitive
deficits, and frontal lobe injury. Poor school
performance in SCD is one indicator of SCI.

Neurocognitive function

Results were small, however, there was a 4.3
difference in IQ when comparing children with
SCD to healthy controls. *Note: Analysis
consolidated various measures of intelligence.

(Continued)
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Author(s)

Silva et al.

Smith et al.

Switzer, Hess, Nichols,
& Adams

Thogmartin et al

Thust, Burke, &
Siddiqui

van der Land et al.

Year

Title

Methodology &
Sample

2009

Brain magnetic
resonance imaging
abnormalities in adult
patients with sickle
cell disease:
Correlation with
transcranial doppler
findings

Cross-sectional study
in which 50 adult
patients with SCD
underwent MRI.

Prospective cohort
study in which 232
patients with SCD
age 16 and older
completed a daily
pain diary for up to 6
months.
Literature review of
the epidemiology,
clinical spectrum,
and pathophysiology
of stroke in SCD to
identify potential
therapeutic targets.

94

Psychometric Measures

N/A

Outcomes

Neuroimaging findings

MRI abnormalities were noted in 60% of adult
patients with SCD which is higher than the
incidence seen in healthy children.

Pain

Pain in patients with SCD is primarily managed
at home; however, pain episodes should be
considered the rule rather than the exception.
Previous studies likely underestimate the
prevalence of pain in the SCD population.

Therapeutic targets

Overt strokes are associated with occlusion of
the larger arteries while silent stroke is
associated with occlusion of the smaller arteries
and more commonly affect white matter.

Mortality

An analysis of SCT fatality indicated that despite
seeking medical treatment, SCT-related microocclusive crisis (often associated with exertion)
was inadequately considered in the differential
diagnosis. Several of these cases were associated
with sudden death.

2008

Daily assessment of
pain in adults with
sickle cell disease

2006

Pathophysiology and
treatment of stroke in
sickle-cell disease:
present and future

2011

Sickle cell traitassociated deaths: A
case series with a
review of the
literature

Case study and
literature review of
16 expired
individuals with
SCT.

2014

Neuroimaging
findings in sickle cell
disease

Literature review of
the neuroradiological
findings in patients
with SCD.

N/A

Neuroimaging findings

2016

Risk factor analysis
of cerebral white
matter
hyperintensities in
children with sickle
cell disease

Cross-sectional study
in which 40 children
with SCD underwent
medical workup
including MRI.

N/A

Neuroimaging findings

N/A

N/A

N/A

Relevant Findings

Neuroradiological findings in patients with SCD
are common and are typically, but not always,
due to vasculopathy. Coexisting acute and
chronic pathology may pose challenges to
interpretation.
Several key points were made. Firstly, boys are
at an increased risk for WMH. Secondly, lower
HbF was associated with larger WMH volume.
This suggests that HbF may be protective for
WMHs and endothelial dysfunction may
contribute to the development of WMHs by
reducing cerebral blood flow.
(Continued)
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Author(s)

Vichinsky et al.

Wang et al.

Webb & Kwiatkowski

Yanamandra et al.

Year

Title

Methodology &
Sample

2010

Neuropsychological
dysfunction and
neuroimaging
abnormalities in
neurologically intact
adults with sickle cell
anemia

Cross-sectional study
in which 149 adult
participants with
SCA underwent
neuropsychological
screening and MRI.

2001

Neuropsychologic
performance in
school-aged children
with sickle cell
disease: A report
from the Cooperative
Study of Sickle Cell
Disease

Longitudinal study in
which 373 children
with SCD underwent
neuropsychological
screening battery as
well as MRI

2013

Stroke in patients
with sickle cell
disease

2018

A case of
autosplenectomy in
sickle cell trait
following an
exposure to high
altitude

Literature review
which discusses the
current understanding
of the epidemiology,
risk factors, and
pathophysiology of
small and large
vessel disease,
primarily in
pediatrics.
Case study of a 24year-old man with
SCT who
experienced
autosplenectomy
following exposure to
high altitude.

95

Psychometric Measures

Outcomes

Relevant Findings

Neurocognitive function,
Neuroimaging findings

This study was the first to evaluate
neuropsychological outcomes in an adult SCD
population. Although there were no significant
group differences with regard to total gray matter
or hippocampal volume, participants with SCD
demonstrated significantly lower FSIQ and
processing speed when compared to healthy
demographically matched controls.

WJ-R, WISC-R, WISCIII

Neurocognitive function

Researchers evaluated neuropsychological
functioning in a SCD population with history of
SCI (in the absence of overt stroke). Overall,
participants with history of SCI demonstrated
poorer performance than healthy controls on
various measures.

N/A

Overt stroke

This article reviews current understanding of the
epidemiology, risk factors and pathophysiology
of stroke with a focus on pediatrics.

D-KEFS, TEA, WAISIII

N/A

Autosplenectomy

Individuals with SCT can be asymptomatic until
exposure to severe hypoxia at which time they
can manifest clinically with sickle
cell syndrome.
(Continued)

EXECUTIVE FUNCTIONS IN ADULTS WITH SCD

96

References
Allen, T. M., Anderson, L. M., Rothman, J. A., & Bonner, M. J. (2017). Executive functioning
and health-related quality of life in pediatric sickle cell disease. Child Neuropsychology,
27(8), 889-906. https://doi.org/10.1080/09297049.2016.1205011.
Anie, K. A., & Green, J. (2015). Psychological therapies for sickle cell disease and pain. The
Cochrane Library. https://doi.org/10.1002/14651858.cd001916.pub3.
Armstrong, F. D., Pavlakis, S., Goldman, M. L., Thompson, W., & Cuadra, A. (2010).
Neurocognitive outcomes in sickle cell disease. In Nass, R., & Frank, Y. (Eds.).
Cognitive and behavioral abnormalities of pediatric diseases (pp. 285-292). London,
U.K.: Oxford University Press.
Baker, R. B., Washington, H. A., Olakanmi, O., Savitt, T. L., Jacobs, E. A., Hoover, E., &
Wynia, M. K. (2008). African American physicians and organized medicine, 1846-1968:
Origins of a racial divide. JAMA, 300(3), 306-313.
https://doi.org/10.1001/jama.300.3.306.
Brown, R. T., Davis, P. C., Lambert, R., Hsu, L., Hopkins, K., & Eckman, J. (2000).
Neurocognitive functioning and magnetic resonance imaging in children with sickle cell
disease. Journal of Pediatric Psychology, 25(7), 503-513.
https://doi.org/10.1093/jpepsy/25.7.503.
Cahill, C. R., Leach, J. M., McClure, L. A., Irvin, M. R., Zakai, N. A., … Cushman, M. (2019).
Sickle cell trait and cognitive function in African Americans: The reasons for geographic
and racial differences in stroke (REGARDS) cohort. EClinicalMedicine, 11, 27-33.
https://doi.org/10.1016/j.eclinm.2019.05.003.
Christ, S. E., Moinuddin, A., McKinstry, R. C., DeBaun, M., & White, D. A. (2007). Inhibitory
control in children with frontal infarcts related to sickle cell disease. Child
Neuropsychology, 13(2), 132-141. https://doi.org/10.1080/09297040500346563.
Crawford, R. D. & Jonassaint, C. R., (2016). Adults with sickle cell disease may perform
cognitive tests as well as controls when processing speed is taken into account: A
preliminary case-control study. Journal of Advanced Nursing, 72(6), 1409-1416.
https://doi.org/10.1111/jan.12755.
DeBaun, M. R., Armstrong, F. D., McKinstry, R. C., Ware, R. E., Vichinsky, E., & Kirkham, F.
J. (2012). Silent cerebral infarcts: A review on a prevalent and progressive cause of
neurologic injury in sickle cell anemia. Blood, 119(20), 4587-4596.
https://doi.org/10.1182/blood-2011-02-272682.
DeBaun, M. R., Schatz, J., Siegel, M. J., Koby, M., Craft, S., Resar, L., ... & Noetzel, M. (1998).
Cognitive screening examinations for silent cerebral infarcts in sickle cell
disease. Neurology, 50(6), 1678-1682. https://doi.org/10.1212/wnl.50.6.1678.

EXECUTIVE FUNCTIONS IN ADULTS WITH SCD

97

El-Haj, N., & Hoppe, C. (2018). Newborn screening for SCD in the USA and Canada.
International Journal of Neonatal Screening, 4(4), 36.
https://doi.org/10.3390/ijns4040036.
Gaston, M. H., Verter, J. I., Woods, G., Pegelow, C., Kelleher, J., Presbury, G., ... & Diamond,
S. (1986). Prophylaxis with oral penicillin in children with sickle cell anemia. New
England Journal of Medicine, 314(25), 1593-1599.
https://doi.org/10.1056/NEJM198606193142501.
Hijmans, C. T., Grootenhuis, M. A., Oosterlaan, J., Heijboer, H., Peters, M., & Fijnvandraat, K.
(2011). Neurocognitive deficits in children with sickle cell disease are associated with the
severity of anemia. Pediatric Blood & Cancer, 57(2), 297-302.
https://doi.org/10.1002/pbc.22892.
Jacobs, E. A., Rolle, I., Ferrans, C. E., Whitaker, E. E., & Warnecke, R. B. (2006).
Understanding African Americans’ views of the trustworthiness of physicians. Journal of
General Internal Medicine, 21(6), 642.https://doi.org/10.1111/j.15251497.2006.00485_1.x.
Jorgensen, D. R., Metti, A., Butters, M. A., Mettenburg, J. M., Rosano, C., & Novelli, E. M.
(2017). Disease severity and slower psychomotor speed in adults with sickle cell disease.
Blood Advances, 1(21), 1790-1795. https://doi.org/10.1182/bloodadvances.2017008219.
Kassim, A. A., Pruthi, S., Day, M., Rodeghier, M., Gindville, M. C., Brodsky, M. A., ... &
Jordan, L. C. (2016). Silent cerebral infarcts and cerebral aneurysms are prevalent in
adults with sickle cell anemia. Blood, 127(16), 2038-2040. https://doi.org/10.1182/blood2016-01-694562.
Kawadler, J. M., Clayden, J. D., Clark, C. A., & Kirkham, F. J. (2016). Intelligence quotient in
paediatric sickle cell disease: A systematic review and meta‐analysis. Developmental
Medicine & Child Neurology, 58(7), 672-679. https://doi.org/10.1111/dmcn.13113.
Kawadler, J. M., Kirkham, F. J., Clayden, J. D., Hollocks, M. J., Seymour, E. L., Edey, R., ... &
Cox, T. C. (2015). White matter damage relates to oxygen saturation in children with
sickle cell anemia without silent cerebral infarcts. Stroke, 46(7), 1793-1799.
https://doi.org/10.1161/strokeaha.115.008721.
Kinney, T. R., Sleeper, L. A., Wang, W. C., Zimmerman, R. A., Pegelow, C. H., OheneFrempong, K., ... & Gallagher, D. M. (1999). Silent cerebral infarcts in sickle cell
anemia: A risk factor analysis. Pediatrics, 103(3), 640-645.
https://doi.org/10.1542/peds.103.3.640.
Mackin, R., Insel, P., Truran, D., Vichinsky, E. P., Newumayr, L. D., Gold, J. I., . . . Weiner, M.
W. (2014). Neuroimaging abnormalities in adults with sickle cell anemia. Neurology,
82(10), 835-841. https://doi.org/10.1016/j.yped.2010.12.063.

EXECUTIVE FUNCTIONS IN ADULTS WITH SCD

98

Niihara, Y., Miller, S. T., Kanter, J., Lanzkron, S., Smith, W. R., Hsu, L. L., ... & Guillaume, E.
(2018). A phase 3 trial of l-glutamine in sickle cell disease. New England Journal of
Medicine, 379(3), 226-235. https://doi.org/10.1056/nejmc1811050
Ohene-Frempong, K., Weiner, S. J., Sleeper, L. A., Miller, S. T., Embury, S., Moohr, J. W., . . .
Cooperative Study of Sickle Cell Disease. (1998). Cerebrovascular accidents in sickle
cell disease: Rates and risk factors. Blood, 91(1), 288-294.
https://doi.org/10.1182/blood.V91.1.288.
Paquin, H., Trottier, E. D., Pastore, Y., Robitaille, N., Dore Bergeron, M. J., & Bailey, B. (2019).
Evaluation of a clinical protocol using intranasal fentanyl for treatment of vaso-occlusive
crisis in sickle cell patients in the emergency department. Paediatrics & Child Health,
pxz002. https://doi.org/10.1093/pch/pxz022
Paulukonis, S. T., Feuchtbaum, L. B., Coates, T. D., Neumayr, L. D., Treadwell, M. J., …
Hulihan, M. M. (2016). Emergency department utilization by Californians with sickle
cell disease. Pediatric Blood & Cancer, 64(6), 1-6. https://doi.org/10.1002/pbc.26390
Pegelow, C. H., Mackin, E. A., Moser, F. G., Wang, W. C., Bello, J. A., Miller, S. T., . . .
Kinney, T. R. (2002). Longitudinal changes in brain magnetic resonance imaging
findings in children with sickle cell disease. Blood, 99(8), 3014-3018.
https://doi.org/10.1182/blood.v99.8.3014.
Rees, D. C., Olujohungbe, A. D., Parker, N. E., Stephens, A. D., Telfer, P., & Wright, J. (2003).
Guidelines for the management of the acute painful crisis in sickle cell disease. British
Journal of Haematology, 120(5), 744-752. https://doi.org/10.1046/j.13652141.2003.04193.x.
Routhieaux, J., Sarcone, S., & Stegenga, K. (2005). Neurocognitive sequelae of sickle cell
disease: Current issues and future directions. Journal of Pediatric Oncology Nursing,
22(3), 160-7. https://doi.org/10.1177/1043454205275408.
Schatz, J., Brown, R. T., Pascual, J. M., Hsu, L., & DeBaun, M. R. (2001). Poor school and
cognitive functioning with silent cerebral infarcts and sickle cell
disease. Neurology, 56(8), 1109-1111. https://doi.org/10.1212/wnl.56.8.1109.
Schatz, J., Finke, R. L., Kellett, J. M., & Kramer, J. H. (2002). Cognitive functioning in children
with sickle cell disease: A meta-analysis. Journal of Pediatric Psychology, 27(8), 739748. https://doi.org/10.1093/jpepsy/27.8.739.
Silva, G. S., Vicari, P., Figueiredo, M. S., Carrete, H., Idgawa, M. H., & Massaro, A. R. (2009).
Brain magnetic resonance imaging abnormalities in adult patients with sickle cell disease:
Correlation with transcranial doppler findings. Stroke, 40(7), 2408-12.
https://doi.org/10.1161/STROKEAHA.108.537415.
Smith, W. R., Penberthy, L. T., Bovbjerg, V. E., McClish, D. K., Roberts, J. D., Dahman, B., ...

EXECUTIVE FUNCTIONS IN ADULTS WITH SCD

99

& Roseff, S. D. (2008). Daily assessment of pain in adults with sickle cell disease. Annals
of Internal Medicine, 148(2), 94-101. https://doi.org/10.7326/0003-4819-148-2200801150-00004
Switzer, J. A., Hess, D. C., Nichols, F. T., & Adams, R. J. (2006). Pathophysiology and
treatment of stroke in sickle-cell disease: Present and future. The Lancet Neurology, 5(6),
501-512. https://doi.org/10.1016/s1474-4422(06)70469-0.
Thogmartin, J. R., Wilson, C. I., Palma, N. A., Ignacio, S. S., Shuman, M. J., & Flannagan, L. M.
(2011). Sickle cell trait-associated deaths: A case series with a review of the literature.
Journal of Forensic Sciences, 56(5), 1352-1360. https://doi.org/10.1111/j.15564029.2011.01774.x.
Thust, S. C., Burke, C., & Siddiqui, A. (2014). Neuroimaging findings in sickle cell disease.
British Journal of Radiology, 87(1040). https://doi.org/10.1259/bjr.20130699.
van der Land, V., Mutsaerts, H. J., Engelen, M., Heijboer, H., Roest, M., Hollestelle, M. J., . . .
Fijnvandraat, K. (2016). Risk factor analysis of cerebral white matter hyperintensities in
children with sickle cell disease. British Journal of Haematology, 172(2), 274-285.
https://doi.org/10.1111/bjh.13819.
Vichinsky, E. P., Neurmayr, L. D., Gold, J. I., Weiner, M. W., Rule, R. R., Truran, D., . . .
Armstrong, F. (2010). Neuropsychological dysfunction and neuroimaging abnormalities
in neurologically intact adults with sickle cell anemia. JAMA, 303(18), 1823-1831.
https://doi.org/10.1001/jama.2010.562.
Wang, W., Enos, L., Gallagher, D., Thompson, R., Guarini, L., Vichinsky, E., . . . Armstrong, F.
(2001). Neuropsychologic performance in school-aged children with sickle cell disease:
A report from the Cooperative Study of Sickle Cell Disease. Journal of Pediatrics,
139(3), 391-397. https://doi.org/10.1067/mpd.2001.116935.
Webb, J., & Kwiatkowski, J. L. (2013). Stroke in patients with sickle cell disease. Expert Review
of Hematology, 6(3), 301-16. https://doi.org/10.1586/ehm.13.25.
Yanamandra, U., Das, R., Malhotra, P., & Varma, S. (2018). A case of autosplenectomy in sickle
cell trait following an exposure to high altitude. Wilderness & Environmental Medicine,
29(1), 85-89. https://doi.org/10.1016/j.wem.2017.08.021.

EXECUTIVE FUNCTIONS IN ADULTS WITH SCD
Appendix B
IRB Approval

100

